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ABSTRACT 
Objective: The study aimed to estimate the prevalence of diabetes and 
retinopathy in people with normal and abnormal glucose metabolism in rural 
Bangladesh and to identify the associated risk factors for developing diabetes 
and retinopathy in this population.  
Methods: This population based cross-sectional study was conducted 
through screening in camp settings, which included a total of 836 participants 
(aged ≥25 years) by following simple random procedure. Fasting blood 
glucose (FBG) and oral glucose tolerance test (OGTT) were performed for all 
participants to diagnosis diabetes according to the diagnostic criteria of World 
Health Organization. Retinopathy was determined by ophthalmoscopy and 
fundus photography. Anthropometric measurements (BMI and WHR), 
glycosylated hemoglobin, blood pressure, lipid profile and urine albumin 
creatinine ratio were also observed. Logistic regression analysis was used, 
without and with adjustment for potential confounders. 
Results: An increased prevalence of diabetes and retinopathy was found with 
7.2% (95% CI 5.4-9.0) and 5.4% (95% CI 3.9-6.9) in the present study, 
respectively. Moreover, the prevalence of retinopathy among the diabetic, 
prediabetic and nondiabetic subjects were 21.6% (95% CI 11.2-32.0), 13% (95% 
CI 3.4-22.6) and 3.5% (95% CI 2.2-4.8), respectively. A superior agreement was 
observed between FBG and OGTT (Kappa value 0.86) among the study 
participants. After adjusting for potential confounders BMI, WHR, serum 
creatinine, triglyceride, total cholesterol and UACR were found as significant 
independent risk indicators for the occurrence of diabetes and age, BMI, 
hypertension, HbA1c, serum creatinine total cholesterol and UACR were also 
found as significant independent risk indicators for the occurrence of 
retinopathy in this population.  
Conclusion: The indices of obesity (increased BMI and WHR), hyperlipidemia 
(increased triglyceride and cholesterol), serum creatinine and urine ACR may at least 
in part explain the high prevalence of diabetes mellitus and retinopathy in this rural 
population of Bangladesh. 
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1  INTRODUCTION 
1.1 BANGLADESH – A brief country profile 
Bangladesh officially the People's Republic of Bangladesh is a country in 
South Asia. The name Bangladesh means "Country of Bengal" in the official 
Bengali language. Straddling the Ganges/Brahmaputra delta, Bangladesh is 
low-lying riverine land traversed by the many branches and tributaries of the 
Ganges and Brahmaputra rivers. It is among the most densely populated 
countries in the world and has a high poverty rate and vulnerable to natural 
disaster. As the  
 
World Bank notes in its July 2005 Country Brief, the country has made 
significant progress in human development in the areas of literacy, gender 
parity in schooling and reduction of population growth (1). However, 
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Bangladesh continues to face a number of major challenges, including 
widespread political and bureaucratic corruption, and economic competition 
relative to the world.A brief overview of the country is given below: 
Full name: People's Republic of Bangladesh  
Term for citizen (s): Bangladeshi 
Independence: 16 December 1971 (from West Pakistan); note - 26 March 1971 
is the date of independence declaration from West Pakistan, 16 December 
1971 is known as Victory Day and commemorates the official creation of the 
state of Bangladesh. 
National flag: Green field with a large red disk shifted slightly to the hoist 
side of center; the red disk represents the rising sun and the sacrifice to 
achieve independence; the green field symbolizes the lush vegetation of 
Bangladesh. 
Capital city: Dhaka 
Location: Southern Asia, bordering the Bay of Bengal, between Myanmar 
(Burma) and India  
Area: Total area 144,000 sq km (55,599 sq miles). land - 133,910 sq km and 
water - 10,090 sq km 
Land boundaries: Total 4,246 km. Border countries: Myanmar193 km, India 
4,053 km 
Climate: Tropical, mild winter (October to March); hot, humid summer 
(March to June); humid, warm rainy monsoon (June to October)  
Terrain: Mostly flat alluvial plain; hilly in southeast  
Natural resources: Natural gas, arable land, timber, coal 
Natural hazards: Droughts, cyclones; much of the country routinely 
inundated during the summer monsoon season 
Population: 153,546,896 (2008 estimate) 
Density: 1146/ sq km (11th position) (2008 est.) 
Age structure: 0-14 years: 33.4% (male 26,364,370/female 24,859,792)  
15-64 years: 63.1% (male 49,412,903/female 47,468,013)  
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65 years and over: 3.5% (male 2,912,321/female 2,529,502) (2008 
est.) 
Population growth rate: 2.022% (2008 est.) 
Birth rate: 28.86 births/1,000 population (2008 est.) 
Death rate: 8 deaths/1,000 population (2008 est.) 
Sex ratio: Total population: 1.05 male(s)/female (2008 est.) 
Infant mortality rate: Total: 57.45 deaths/1,000 live births  
Male: 58.44 deaths/1,000 live births  
Female: 56.41 deaths/1,000 live births (2008 est.) 
Life expectancy at birth: Total population: 63.21 years  
Male: 63.14 years  
Female: 63.28 years (2008 est.) 
Total fertility rate: 3.08 children born/woman (2008 est.) 
Ethnic groups: Bengalis (98%), other 2% (includes tribal groups, non-Bengali 
Muslims) 
Languages: Bangla (official, also known as Bengali), English and some tribal 
languages. 
English is quite widely spoken by those with education. 
Religions: Islam (83%), Hinduism (16%). Buddhists and Christians make up 
about 1% 
of the population 
Literacy: Definition: Age 15 and over can read and write.  
Total population: 43.1%  
Male: 53.9%  
Female: 31.8% (2003 est.) 
Currency: Taka (BDT) 
GDP: Per capita USD 1311 (153rd position) (2007 est.) 
GNI: Per capita USD 470 (2007 est.) 
Major political parties: Bangladesh Nationalist Party (BNP), Bangladesh 
Awami League (AL), Jamaat-e-Islami Bangladesh, Jatiya Party (N) (JPN). 
Government: Bangladesh is a Parliamentary Democracy with a non-executive 
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President elected by Parliament. Parliament and President are both elected for 
five years.  
Head of State: President Zillur Rahman  
Prime Minister: Sheikh Hasina Wazed 
Membership of international groupings/organisations: Commonwealth, 
SAARC, UN, Organisation of Islamic Countries (OIC)  (2, 3, 4). 
Geography: 
The area that is now Bangladesh has a rich historical and cultural past, 
combining Dravidian, Indo-Aryan, Mongol/Mughul, Arab, Persian, Turkic, 
and west European cultures. Bangladesh is bordered on the west, north, and 
east by Indian territory except for a short south-eastern frontier with 
Myanmar (Burma) and borders the Bay of Bengal in the south. Together with 
the Indian state of West Bengal, it makes up the ethno-linguistic region of 
Bengal. Most of the country is situated on deltas of large rivers flowing from 
the Himalayas: the Ganges, known as the Padma unites with the Jamuna 
(main channel of the Brahmaputra) and later joins the Meghna to eventually 
empty into the Bay of Bengal. To the east of the delta lie the only significant 
area of hilly terrain, constituting less than one-tenth of the nation's territory, is 
the Chittagong Hill Tracts in the narrow southeastern panhandle of the 
country. The highest point is located in the south-eastern extremity of 
Chittagong Hill Tracts. Bangladesh remains vulnerable to natural disasters 
and to the impact of climate change. Arable land is extremely fertile. 
Bangladesh's principal natural resource is natural gas (2, 4). 
Climate 
Traditionally Bangladeshis subdivide the year into six seasons: Grismo 
(summer), Barsha (rainy), Sharat (autumn), Hemanto (cool), Sheet (winter), 
and Bashonto (spring). For practical purposes, however, three seasons are 
distinguishable: summer, rainy, and winter. Bangladeshi climate is tropical 
and governed by the monsoon winds with a mild winter from October to 
March; a hot, humid summer from March to June. A warm and humid 
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monsoon season lasts from June to October and supplies most of the country's 
rainfall. In summer (March to September) the monsoon winds bring very 
heavy rainfall (up to 200 inches), often accompanied by cyclonic storms. The 
short winter is relatively dry. In winter the mean temperature is about 16 
degrees centigrade (53F) and in summer 33 degrees centigrade (91F).  
Bangladesh is now widely recognized to be one of the countries most 
vulnerable to climate change. Natural calamities, such as floods, tropical 
cyclones, tornadoes and tidal bores occur almost every year, combined with 
the effects of deforestation, soil degradation and erosion. Flooding is normal 
and life has adapted to take account of this almost in each year. But 
occasionally excessive flooding, as in 1988, 1998, and 2004 causes widespread 
destruction and loss of life. There were several reasons for the severity of the 
flooding. Firstly, there were unusually high monsoon rains. Secondly, the 
Himalayas shed off an equally unusually high amount of melting water. Trees 
that usually intercept rain water were cut down for firewood or to make space 
for animals. Natural hazards that come from increased rainfall, sea level rise, 
and tropical cyclones are expected to increase as climate change, each 
seriously affecting agriculture, water & food security, human health and 
shelter. It is believed that in the coming decades the rising sea level alone will 
create more than 25 million climate refugees (2, 5-8).  
Land   
Bangladesh is a land of rivers that crisscrossed throughout the mostly flat 
territories of the country. A humid, low-lying, alluvial region, Bangladesh is 
composed mainly of the great combined delta of the Padma, Jamuna and 
Meghna, with a network of numerous rivers and canals. Except for the 
Chittagong Hills along the Myanmar border, most of the country is no more 
than 300 ft (90 m) above sea level. Vast green fields are hounded by low hills 
in the northeast and the southeast with an average elevation of 244 and 610 
metres respectively. Bangladesh is laced with numerous streams, 
distributaries, and tidal creeks, forming an intricate network of waterways 
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that constitutes the country's chief transportation system. Along the 
southwestern coast is the Sundarbans, a mangrove swamp area with 
numerous low islands. The low-lying delta region is subject to severe flooding 
from monsoon rains, cyclones (hurricanes), and storm surges that bring major 
crop damage and high loss of life. The cyclones of 1970 and 1991 and the 
monsoon floods of 1988, 1998, and 2004 were particularly devastating. 
People  
Bangladesh is one of the world's ten most populated countries and has one of 
the highest population densities (about 1146 people per sq km). Regionally, 
the eastern districts have a slightly higher density than the western ones. On 
average, a household consists of 5.6 persons. The level of urbanization is low 
at 20% but it has a predominantly rural population, with over 75% which 
primarily depend on a poorly developed agriculture for livelihood. The 
capital city of Dhaka has an estimated population of 8.58 million. The annual 
growth rate of the population has come down to around 2% with the 
acceptance of family planning practices rising to 48.7%. The tribal people, 
who lead a simple life, are generally self-reliant, producing their own food 
and drinks and weaving their own clothes. The great majority of Bangladesh's 
population is Bengali, although Biharis and several tribal groups constitute 
significant minority communities. About 83% of the population is Sunni 
Muslim and 16% is Hindu. Bangla (Bengali) is the nation's official language, 
and English is used in urban centers.  
Economy 
Bangladesh is one of the world's poorest nations, with overpopulation adding 
to its economic woes, and it is heavily reliant on foreign aid. Major 
impediments to growth include frequent cyclones and floods, the inefficiency 
of state-owned enterprises, a rapidly growing labor force that cannot be 
absorbed by agriculture, delays in exploiting energy resources (natural gas), 
and inadequate power supplies. The country's economy is based on 
agriculture. Rice, jute, tea, wheat, sugarcane, and tobacco are the chief crops. 
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Bangladesh is the world's largest producer of jute. Fishing is also an 
important economic activity, and beef, dairy products, and poultry are also 
produced. Except for natural gas (found along its eastern border), limited 
quantities of oil (in the Bay of Bengal), coal, and some uranium, Bangladesh 
possesses few minerals. 
Dhaka and Chittagong (the country's chief port) are the principal industrial 
centers; clothing and cotton textiles, jute products, newsprint, and chemical 
fertilizers are manufactured, and tea is processed. In addition to clothing, jute, 
and jute products, exports include tea, leather, fish, and shrimp. Remittances 
from several million Bangladeshis working abroad are the second largest 
source of foreign income. Capital goods, chemicals, iron and steel, textiles, 
food, and petroleum products are the major imports. Western Europe, the 
United States, India, and China are the main trading partners. 
History 
Before the independence of India and Pakistan, the territory formed part of 
the Indian provinces of Bengal and Assam. Following partition in 1947, East 
Bengal, with a Muslim majority population, emerged as the eastern wing of 
Pakistan. During the period of East and West Pakistan there was a growing 
sense of Bengali nationalism, stimulated in part by the insensitivity of the 
central Government in West Pakistan, particularly on language (Urdu was 
declared the official language although few in East Pakistan spoke it). 
In the 1970 general elections the Awami League (AL), a Bengali nationalist 
party led by Sheikh Mujibur Rahman, won a landslide victory in East 
Pakistan. Since the East had the larger population this gave it an absolute 
majority in the national parliament. After West Pakistan failed to recognise 
the AL's majority, Sheikh Mujib launched a secessionist uprising. The 
Pakistan Government responded with vicious military tactics, including the 
targeted murder of “intellectuals” (including many Hindus) and mass rape. 
This eventually led to the intervention of the Indian army and the new state of 
Bangladesh was declared independent on 16 December 1971. 
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Government 
Bangladesh is a parliamentary democracy with Islam as the state religion. 
Direct elections involving all citizens over the age 18 are held every five years 
for the unicameral parliament known as Jatiyo Sangshad. The parliament 
building is known as the Jatiyo Sangshad Bhaban designed by architect Louis 
Kahn and currently has 345 members including 45 reserved seats for women, 
elected from single-member constituencies. The Prime Minister, as the head of 
the government, forms the cabinet and runs the day-to-day affairs of state. He 
or she must be a member of parliament who commands the confidence of the 
majority of parliament. The President is the head of the state, a largely 
ceremonial post elected by the parliament.  
However the President's powers are substantially expanded during the tenure 
of a Caretaker Government, which is responsible for the conduct of elections 
and transfer of power. The officers of the caretaker government must be non-
partisan and are given three months to complete their task. This transitional 
arrangement is an innovation that was pioneered by Bangladesh in its 1991 
election and then institutionalized in 1996 through its 13th constitutional 
amendment. 
Bangladesh went ahead with its general election in December 2008. It was the 
first general election since the army-backed caretaker government took power 
in January 2007. The Awami League, headed by Sheikh Hasina, won in a 
landslide, taking 262 of 299 seats in Parliament. The vote was considered fair 
and largely free of scandal. Sheikh Hasina was sworn in as prime minister in 
January 2009. 
Health status & Health service delivery 
Although Bangladesh had a basic health care infrastructure in the 1980s, 
much remained to be done, particularly in rural areas, where health care is 
inaccessible for many people and the majority of the people faced critical 
health problems. The incidence of communicable disease was extensive, and 
there was widespread malnutrition. Poor standards of hygiene and sanitation, 
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inadequate sewage disposal, and inadequate supplies of safe drinking water 
cause up to 80% of diseases. Flood prone areas are subject to waterborne 
diseases. High levels of maternal and infant mortality are experienced and 
adherence to traditional home births practices is common. Infants suffered 
from chronic malnutrition. There is a risk of dengue and malaria fever 
throughout Bangladesh. There are significant geographical variations in the 
incidence and prevalence of disease. 
The Ministry of Health and Family Planning was responsible for developing, 
coordinating, and implementing the national health and mother-and-child 
health care programs. Less than 40 percent of the population has access to the 
basic health care services, and overall health care performance remained 
unacceptably low by all conventional measurements. Program 
implementation, however, was limited by severe financial constraints, 
insufficient program management and supervision, personnel shortages, 
inadequate staff performance, and insufficient numbers of buildings, 
equipment, and supplies. Immunization and family planning programmes 
have been successful but Bangladesh is still the world's most densely 
populated country. Improving health care in Bangladesh will be an enormous 
task. 
1.2 Global Burden of Diseases 
Non-communicable Diseases 
Bangladesh has been experiencing an epidemiological transition from 
communicable diseases to non-communicable diseases (NCDs). NCDs are 
important cause of disease burden, morbidity and mortality. At least 25% of 
the deaths in primary and secondary government health facilities are caused 
by these diseases. Presently, Bangladesh does not have a community-based 
public health program for NCDs. Only hospital-based information, although 
poor, is available. However, exact situation in the country is not known 
because of lack of representative data, lack of advocacy, lack of logistic and 
other facilities for initiation of efficient surveillance system on NCDs, as well 
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as difficulties in the generating resources for newer initiatives. Surveillance 
for a few communicable diseases is known to exist although it needs major 
improvement. Unfortunately there is no national surveillance system for non-
communicable diseases. The Health, Nutrition, Population Sector Programme 
(HNPSP) has identified three NCDs- cancer, cardiovascular diseases and 
diabetes mellitus- as major public health problems. Therefore surveillance of 
these diseases should be started to assist in formulating country policies and 
programmes. They have a few common risk factors for which Bangladesh 
does not have representative data to be addressed for primary prevention. 
Tertiary level hospital data indicate that cardiovascular diseases have already 
appeared as one of the leading causes of mortality. Bangladesh Institute of 
Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders 
(BIRDEM) and its sister organizations has initiated surveillance of diabetes 
mellitus all over the country. 
1.3 Diabetes Mellitus 
Diabetes mellitus (DM) is a group of metabolic disorder with multiclinical 
features characterized by high blood glucose levels, with disturbances of 
carbohydrate, fat and protein metabolism, resulting from insulin secretion, or 
insulin action or both. Diabetes mellitus, commonly referred to as diabetes, 
means “sweet urine”. Elevated levels of blood glucose (hyperglycemia) lead 
to spillage of glucose into the urine, hence the term sweet urine. Glucose is the 
main source of energy for the body's cells. Normally, the levels of glucose in 
the blood are tightly controlled by a hormone called insulin, which is made by 
the pancreas. Insulin helps glucose enter the cells and thus lowers the blood 
glucose level. When blood glucose elevates (for example, after eating food), 
insulin is released from the pancreas to normalize the glucose level. In 
patients with diabetes, the pancreas does not make enough insulin or the 
body can't respond normally to the insulin that is made. This causes glucose 
levels in the blood to rise, leading to symptoms such as increased urination, 
extreme thirst, and unexplained weight loss. Diabetes mellitus is also an 
important factor in accelerating the hardening and narrowing of the arteries, 
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leading to coronary heart diseases, strokes, and other blood vessel diseases. 
Diabetes mellitus is a chronic medical condition, meaning that although it can 
be controlled, it lasts a lifetime. Uncontrolled and poorly controlled diabetes 
increase the risk of macro-and micro vascular disorders, infections, 
dysfunction and other associated problems. Long-term DM may lead to 
complications in any organ of the body, but main target organs are heart, 
kidney, nerves and eyes. 
Classification of Diabetes Mellitus 
According to World Health Organization (WHO) diabetes mellitus has been 
classified into two types:  type 1 diabetes mellitus and type 2 diabetes mellitus 
(WHO, 1999). Beside that gestational diabetes mellitus is another known type 
of diabetes. 
Type 1 diabetes: It was previously called insulin dependent diabetes or 
juvenile onset diabetes. This is immune mediated diabetes. Type 1 diabetes 
mellitus results from an absolute deficiency of insulin due to autoimmune 
destruction of the insulin producing pancreatic beta cell (9). This type of 
diabetes can affect generally in early stage of life and insulin is required for 
survival. It has multiple genetic predispositions and has also been said to be 
related to environmental factors, though still poorly defined. This type of 
diabetes, account for 5-10% of those with diabetes. 
Type 2 diabetes: Type 2 diabetes mellitus, the commonest form of diabetes is 
also called non-insulin dependent diabetes mellitus or adult onset diabetes. 
This type of diabetes is characterized by insulin resistance and/or abnormal 
insulin secretion, either of which may predominate (10, 11). Type 2 diabetes 
mellitus, account for approximately 90-95% of those with diabetes. Type 2 
diabetes mellitus is a disorder entirely separate from type 1 diabetes mellitus. 
Relative beta-cell insufficiency is, by definition, present in all individuals with 
type 2 DM. The disorder, in most cases, is also characterized by insulin 
resistance detected at the level of skeletal muscle, adipose tissue, and the liver. 
Insulin resistance at the former site results in decreased peripheral glucose 
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disposal, while the latter, in increased hepatic glucose production. In many 
individuals, the natural history of type 2 DM begins with a period of insulin 
resistance with preserved, indeed augmented, pancreatic insulin secretion, as 
the insensitivity to insulin action in peripheral tissues is overcome by 
hyperinsulinemia. As a result, plasma glucose concentrations remain 
relatively normal. As the disease progresses, however, pancreatic islet cell 
function falters and it is no longer able to meet the peripheral demand. As a 
result, insulin levels fail to keep up with requirements, and hyperglycemia 
ensues. 
Gestational diabetes mellitus: Gestational diabetes mellitus (GDM) is 
defined as any degree of glucose intolerance with onset or first recognition 
during pregnancy. The definition applies regardless of whether insulin or 
only diet modification is used for treatment or whether the condition persists 
after pregnancy. It does not exclude the possibility that unrecognized glucose 
intolerance may have begun along with the pregnancy. GDM complicates 4% 
of all pregnancies in the U.S., resulting in 135,000 cases annually. The 
prevalence may range from 1 to 14% of pregnancies, depending on the 
population studied. Deterioration of glucose tolerance occurs normally during 
the 3rd trimester of pregnancy.  
1.4 Global Trend of Diabetes Mellitus 
In recent years, diabetes mellitus (DM) appears to be a global health problem. 
It is one of the leading causes of death, disability and economic loss through 
out the world.  Diabetes affects persons of all ages and races. The disease 
reduces both a person’s quality of life and life expectancy and imposes a large 
economic burden on the health care system and on families. 
According to the World Health Organization (WHO) Report there were 171 
million people worldwide with DM in 2000 and predicted that 366 million 
people will have DM by 2030 (P1: 1). The International Diabetes Federation 
has estimated that another 314 million persons have impaired glucose 
tolerance and that number will increase to 472 million by 2030 (12). In 2003, 
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the worldwide prevalence of diabetes mellitus was estimated at 5.1 percent 
among people age 20 to 79. By 2025, the worldwide prevalence is projected to 
be 6.3 percent, a 24 percent increase compared with 2003 (13). 
The prevalence of DM is reaching epidemic proportions. The prevalence of 
diabetes was higher in developed countries than in developing countries (13). 
However, it is estimated that the developing countries will bear the brunt of 
this epidemic in the 21st century, with 80% of all new cases of diabetes 
expected to appear in the developing countries by 2025 (P1: 2). In the 
developing world, the prevalence was highest in Europe and Central Asia 
and lowest in Sub-Saharan Africa. Some of these variations may reflect 
differences in the age structures and level of urbanization of the various 
populations. The largest increase in prevalence by 2025 is expected to be in 
the Middle-East, Sub-Saharan Africa, South Asia, and Latin America (P1: 1). 
In terms of those affected, the biggest increase in the developing countries is 
projected to take place among adults of working age. 
The World Health Organization (WHO) estimates that, in 2001, worldwide 
approximately 1.6 percent of all deaths caused by diabetes mellitus, and 
approximately 3 percent of all deaths caused by non-communicable diseases. 
More recent estimates by WHO suggests that the actual number may be triple 
this estimate and that about two-thirds of these deaths occur in developing 
countries (14). Within the developing regions, most deaths caused by diabetes 
occurred in East Asia and the Pacific and the fewest in Sub- Saharan Africa. 
Diabetes-related complications include microvascular diseases; for example, 
retinopathy, blindness, nephropathy, and kidney failure and macrovascular 
diseases; like, coronary heart disease, stroke, peripheral vascular disease, and 
lower-extremity amputation. Those complications result in disability. In the 
United States, a much higher proportion of people with diabetes than of 
people without diabetes have physical limitations: 66 percent compared with 
29 percent (15). Disabilities are even more pronounced among older people 
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(16). Cardiovascular disease (CVD) causes up to 65 percent of all deaths in 
developed countries of people with diabetes (17). 
1.5 Literature Review: Diabetes Mellitus 
Diabetes mellitus (DM) is becoming a pandemic worldwide. WHO listed 10 
countries to have the highest numbers of people with diabetes in 2000 and 
2030 (P1: 1). Bangladesh appears in the list for both 2000 and 2030 with India, 
Pakistan, China, Japan and USA etc. According to the report, Bangladesh has 
3.2 million of diabetic subjects, and the number is expected to increase to a 
staggering 11.1 million by 2030. Several small-scale population based studies 
conducted in Bangladesh at different time points have revealed an increasing 
trend of diabetes prevalence in rural and urban communities (P1: 3-10). A 
recent population based study (P1: 4) showed a significant increase in the 
prevalence of DM in rural Bangladesh from 2.3% to 6.8% over 5 years. This 
prevalence was higher than found in the previous rural studies of Bangladesh 
(P1: 6, 8). However, the association of obesity and diabetes in this population 
is unconventional. Some studies showed that BMI and WHR were important 
predictors of diabetes in rural Bangladeshi population, although the 
population was considered as lean (P1: 4, 6), while the others did not (P1: 3, 
5). 
The risk for developing diabetes is higher in people with a family history of 
diabetes (18). This finding strongly suggests that genetic determinants play a 
role, but so far few genes have been associated with type 2 diabetes. 
Environmental factors include prenatal factors, obesity, physical inactivity, 
and dietary and socioeconomic factors.  
The strongest and most consistent risk factors for diabetes and insulin 
resistance among different populations are obesity and weight gain (19) for 
each unit increase in body mass index, the risk of diabetes increases by 12 
percent (20). The distribution of fat around the trunk region, or central 
obesity, is also a strong risk factor for diabetes (21). Cardiovascular disease, 
atherosclerosis, hypertension, and stroke are common problems affecting 
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individuals with diabetes, all of which correlate highly with the presence of 
obesity (22, 23). Cardiovascular disease (CVD) is the leading cause of death 
among diabetics, and is responsible for much of the increase in diabetes-
related morbidity and mortality. CVD-related mortality is 2–4 times higher 
among diabetics (22). 
Diabetes risk may be reduced by increasing physical activity. Conversely, a 
sedentary lifestyle and physical inactivity are associated with increased risks 
of developing diabetes (24). Some studies report a positive relationship 
between dietary fat and diabetes, but specific types of fats and carbohydrates 
may be more important than total fat or carbohydrate intake. Increased 
affluence and Westernization have been associated with an increase in the 
prevalence of diabetes in many indigenous populations and in developing 
economies (25, 26). Conversely, in developing countries, those in lower 
socioeconomic groups have a higher risk of obesity and consequently of 
diabetes (27).  
1.6 Retinopathy 
Retinopathy is a general term for all disorders of the retina, the light-sensitive 
membrane at the back of the eye. It is a microvascular disorder affecting the 
small blood vessels in the retina, which includes microaneurysms, retinal 
hemorrhages, and hard exudates. In some people with retinopathy, blood 
vessels may swell and leak fluid. In other people, abnormal new blood vessels 
grow on the surface of the retina. The progression of retinopathy is gradual, 
advancing from mild abnormalities, characterized by increased vascular 
permeability, to moderate and severe nonproliferative retinopathy, 
characterized by vascular closure, to proliferative  retinopathy, characterized 
by the growth of new blood vessels on the retina and posterior surface of the 
vitreous (28). Retinal microvascular abnormality is the leading cause of visual 
disability or acquired blindness. Someone having retinopathy, at first may not 
notice the changes of vision. But over the time, it can get worse and cause 
vision loss. Retinopathy usually affects both eyes. 
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Types of Retinopathy 
The type of retinopathy is often specified. Arteriosclerotic retinopathy is 
retinal disease due to arteriosclerotic ("hardening of the arteries"). 
Hypertensive retinopathy is retinal disease due to high blood pressure. 
Diabetic retinopathy is retinal disease associated with diabetes, etc.  
Arteriosclerotic retinopathy: It is retinal disease caused by arteriosclerotic. In 
this condition, the arterioles (small arteries) in the retina become partially 
blocked because of thickening of their walls. Using an ophthalmoscope, a 
doctor can see the thickened arterioles and other indications of diminished 
blood supply to the retina. (The characteristic features include narrowed 
tortuous arterioles with a "copper wire" appearance, scattered small 
hemorrhages and sharp-edged deposits with no edema around them.) As a 
general rule, arteriosclerotic retinopathy does not damage vision, although it 
is a danger signal that the blood vessels in the body are arteriosclerotic and 
that steps are badly needed to prevent the progression of the disease process. 
Hypertensive Retinopathy: In addition to causing heart and kidney 
problems, untreated hypertension can also affect the eyesight. Hypertension 
can cause damage to the blood vessels in the retina, the area at the back of the 
eye where images focus. This condition is known as hypertensive retinopathy. 
The damage can be serious if hypertension is not treated. Signs of retinopathy 
include, narrowing of blood vessels, fluid oozing from the blood vessels, 
spots on the retina known as cotton wool spots and hard exudates, swelling of 
the macula and optic nerve and bleeding in the back of the eye. The 
professional uses an ophthalmoscope, an instrument that projects light, to 
examine the back of the eyeball. Fluorescein angiography can also use to 
diagnose hypertensive retinopathy. The only way to treat hypertensive 
retinopathy is to diagnose it earlier and treat the hypertension. 
Diabetic retinopathy: Diabetic retinopathy (DR), a common complication of 
diabetes mellitus, affecting the blood vessels in the retina; results from 
chronically high blood glucose levels in people with poorly controlled DM. If 
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untreated, it may lead to blindness. If diagnosed and treated promptly, 
blindness is usually preventable. Diabetic retinopathy begins without any 
noticeable change in vision. But even then there often are extensive changes in 
the retina visible to an ophthalmologist. It is therefore important for a diabetic 
to have an eye examination at least once (ideally twice) a year.  
The diagnosis of diabetic retinopathy is made by a dilated retinal examination 
(eye exam after the eyes are dilated). This may be coupled with a fundus 
fluorescein angiography, a test done to assess the extent and type of changes 
in the retina and its blood vessels. In this test a small amount of dye is injected 
into a vein in the arm and pictures are taken of the eye. Usually this test is 
done as an outpatient procedure.  
1.7 Globally Retinopathy 
Retinopathy, the potential sight threatening condition, is a significant public 
health problem all over the world; however this morbidity is largely 
preventable and treatable. It is significantly associated with impairment of 
vision and blindness. The socioeconomic burden resulting from visual 
impairment or blindness caused by retinopathy, particularly in working age 
group, is a serious concern. According to the World Health Organization 
worldwide there are an estimated 45 million people that are blind with an 
additional 135 million individuals visually impaired (P2: 3). Retinopathy is 
responsible for about 5% of those 45 million cases of blindness throughout the 
world. Retinal disease is more frequent cause of blindness in developing 
countries (P2: 2). Worldwide, the prevalence of retinopathy is increasing at an 
alarming rate, possibly as it has had a low priority in the prevention of 
blindness programs in developing countries. There are several reasons for 
this. Firstly, it was thought that retinal disease was an uncommon cause of 
blindness in the developing world; secondly, that the results of treating retinal 
disease did not justify the effort and expense involved; and, thirdly, that the 
equipment required was too costly and unreliable for use in a developing 
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country environment. Finally, there is a lack of skilled personnel with sub-
speciality training in retinal disease. 
About 20 million Asians were estimated as blind by the World Health 
Organization (WHO), (P2: 4) and this figure is expected to increase as the 
population ages. The excellent and very detailed Andhra Pradesh Eye Disease 
Study (APEDS) found that retinal diseases were a much more common cause 
of adult blindness in India than had previously been thought (P2: 5). As a 
result of the increasing trend of diabetes mellitus, as well as growing problem 
of undetected cases of diabetes mellitus in developing countries, the number 
of people with diabetic complication like diabetic retinopathy will continue to 
rise. With the epidemic increase in diabetes as reported by the World Health 
Organization (WHO), DR is fast becoming an important cause of visual 
disability (29). Global projections suggest that 20% of people with diabetes 
will develop DR (30). A person with diabetes is 25 times more likely to go 
blind than a person in the general population (31). WHO has estimated that 
DR is responsible for 4.8% of the 37 million cases of blindness throughout the 
world (32). 
1.8 Literature Review: Retinopathy 
Retinopathy is very much familiar with its risk factors, clinical presentation, 
and management in patients with diabetes mellitus, commonly termed 
diabetic retinopathy. As a result, Enormous population based data of 
retinopathy in patients with diabetes mellitus, commonly termed as diabetic 
retinopathy (DR) was published. However, other ocular and systemic causes 
of retinopathy or the clinical significance of retinopathy is fairly common in 
adults without diabetes (33-36). Worldwide, the prevalence of retinopathy in 
diabetes population is increasing at an alarming rate due to prolonged 
survival of diabetic patients. It is a significant cause of visual disability both in 
type 1 and type 2 diabetes mellitus in earlier epidemiological studies (37-41). 
The Wisconsin Epidemiological Study of Diabetic Retinopathy (WESDR) the 
widest and most prolonged population based ophthalmologic survey of 
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people with diabetes concluded that retinopathy has been shown to be the 
cause of visual impairment and blindness in 86 % of type 1 diabetic patients 
and in 33 % of type 2 diabetic patients (40). It is estimated that retinopathy 
develops in more than 75% of diabetic patients within 15-20 years of diagnosis 
of diabetes (38, 42). 
There have been many epidemiological studies assessing the prevalence of 
diabetic retinopathy (41, 43-52). About half of the people with diabetes in the 
United States have at least some form of retinopathy (41) where 1 of every 12 
persons with DM in the age group of 40 yrs and above has advanced or 
vision-threatening retinopathy. In Western Europe DR has been reported to 
be the most common cause of blindness among people in working age group 
and the incidence dose not seem to decline (49). There are few population 
based studies on the prevalence of diabetic retinopathy (DR) in Asia, with 
most originating from India (P2: 6-9). In India, DR was the 17th cause of 
blindness 20 years ago; today it has ascended to the 6th position (31). 
However, in the Chennai Urban Rural Epidemiology Eye Study (CURES), 
another population based study found the overall prevalence of DR was 
17.6% (43). 
Non-diabetic retinopathy has been defined in different studies to include 
microaneurysms, retinal haemorrhages, hard exudates, cotton wool spots, 
retinal venular abnormalities, intraretinal microvascular abnormalities, and 
new vessels (33-35). The ocular and systemic causes of retinopathy in people 
without diabetes are varied. Only a few population based research has been 
performed on the prevalence of retinopathy in general population as well as 
at different levels of hyperglycemia, such as, diabetes mellitus, impaired 
glucose tolerance, impaired fasting glucose and normal glucose tolerance (P2: 
29, 30). So far there is not a single study on the extent of this issue has been 
carried out in Asian population.  
Hypertension is probably the best known systemic condition associated with 
retinopathy. In people with hypertension, retinopathy is often referred to as 
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hypertensive retinopathy. Retinopathy has been found to be present in about 
11% of hypertensive non-diabetic people over 43 years of age (34). An 
appreciable proportion (average 6%) of normotensive non-diabetic people 
may also have retinopathy (33-35). In two population based studies, more 
than 50% of the participants with non-diabetic retinopathy did not have a 
history of hypertension (34, 35). Retinopathy may thus represent the 
cumulative effects of elevated blood pressure throughout life in people not 
classified as having hypertension. 
In the Framingham Eye Study, 2.5% of participants who had a dilated 
screening ophthalmoscopic examination were observed to have retinopathy 
(53). After excluding persons with diabetes, the prevalence of retinopathy was 
only 0.8%. In a series of reports from the Beaver Dam Eye study in Wisconsin, 
Klein and colleagues described in detail the prevalence (34, 54, 55) and 5-year 
incidence (56) of retinal microvascular abnormalities, and their relationship 
with hypertension in nondiabetic population. Based on these data (34, 37, 55, 
57), Klein and colleagues have suggested that retinal microvascular 
abnormalities are common in the general nondiabetic population, although 
they are more prevalent in persons with hypertension. In the Blue Mountains 
Eye Study in Australia, using a photographic grading technique similar to 
that used in Beaver Dam, the prevalence of retinopathy was reported at 10% 
(35).  Although this was slightly higher than in Beaver Dam study, the age-
specific rates of retinopathy in men and women were similar between the two 
studies (34, 35, 55). In summary, available epidemiological data suggest that 
retinal microvascular abnormalities can be found in 2–14% of the general 
nondiabetic population, and are fairly common even in persons without 
hypertension. 
Retinopathy lesions are commonly seen in middle aged and elderly people 
with and without diabetes. Signs of retinopathy are structural markers of 
microvascular damage which has been strongly linked with hyperglycemia 
(P2: 11), elevated glycosylated hemoglobin level (P2: 12-14), hypertension (P2: 
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15-17), lower glomerular filtration rates and microalbuminuria (P2: 18). One 
study found that retinopathy was associated with increasing fasting blood 
sugar concentrations in people not classified as having diabetes mellitus (P2: 
19), although another study did not find this association (P2: 16). 
Nevertheless, the distinction between diabetes and pre diabetes is somewhat 
arbitrary, and the results of some recent studies have shown that some of the 
subjects with IGT have had retinopathy (P2: 20, 21). However, if these 
identified risk factors managed with timely diagnosis, the quality of life can 
be preserved.  
1.9 Rationale of the Study 
The latest report from World Health Organization (WHO) (P1: 1) illustrates 
the increasing trend of diabetes mellitus in Bangladeshi population. However, 
several small-scale population based studies conducted in Bangladesh at 
different time points have revealed an increasing trend of diabetes prevalence 
in rural and urban communities. But the pattern of diabetes in Bangladeshi 
population differs from that in Europeans and Americans in several aspects: 
The onset is at a younger age, obesity is less common, and changes in lifestyle 
appear to be stronger. Combination of low BMI and relatively high central 
obesity with increasing prevalence of DM are general features of diabetes in 
Bangladeshi population. However, the association of obesity and diabetes in 
this population is unconventional. These clinical differences and the rising 
prevalence of diabetes in Bangladesh warrant well-conducted epidemiologic 
studies on diabetes including lipid profile, serum creatinine and urine 
albumin creatinine ratio (UACR) as possible confounders for DM in the rural 
population.  
On the other hand, there was only one nationally representative survey 
concerning the extent of blindness or the main causes of vision impairment in 
Bangladeshi adults, which has identified low level of diabetic retinopathy as 
the cause of visual impairment and moreover, no subject was found to be 
blind due to diabetic retinopathy (P2: 22). As the consequences of increasing 
 26
trend of diabetes mellitus, the number of people with diabetic complications 
like retinopathy will continue to rise in Bangladesh. As blindness caused by 
diabetes is largely preventable by good control of the risk factors, early 
detection of retinopathy is an important preventive strategy. Not only the 
patients with diabetes mellitus, but elderly individuals with pre diabetes (IGT 
and IFG) and normal glucose metabolism in general, have a substantial risk of 
developing retinopathy. To the best of our knowledge there is no population 
based study yet in Bangladeshi population either in diabetic or non diabetic 
general population to estimate the magnitude of retinopathy. However, the 
identified risk factors for retinopathy established by others have not been 
extensively studied in our population. The absence of reliable population 
based epidemiological data on retinopathy in Bangladesh is a serious 
impediment to the effective national planning of eye care programmes.  
In the above context, we were attempting to carry out an epidemiological 
study to observe the chronological changes in the prevalence of diabetes 
mellitus and to identify its associated risk factors, as well as, to make a 
baseline data focused on retinopathy in a rural Bangladeshi population. This 
would be the first effort to estimate the prevalence of retinopathy among 
diabetic and non diabetic population in Bangladesh and to identify the 
associated risk factors for developing retinopathy in this adult sample. 
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2  OBJECTIVES 
2.1 General Objective 
The general objective of the study was to estimate the prevalence and risk 
factors of diabetes mellitus and retinopathy in a rural population of 
Bangladesh. 
2.2 Specific Objectives 
The specific objectives of the study were as follows; 
1. To estimate the prevalence of pre diabetes in rural population of 
Bangladesh.  
2. To estimate the prevalence of diabetes in rural population of Bangladesh. 
3. To identify the associated risk factors for diabetes in this population. 
4. To estimate the prevalence of retinopathy in a rural diabetic population of 
Bangladesh. 
5. To estimate the prevalence of retinopathy in a rural non diabetic general 
population. 
6. To identify the associated risk factors for developing retinopathy in 
Bangladeshi rural population. 
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3  SUBJECTS AND METHODS 
3.1 Study Area  
Bangladesh has 64 districts and the study was conducted in one district of 
northern Bangladesh called Thakurgaon. Thakurgaon is in the north-west 
corner of Bangladesh, it is about 467 km from Dhaka, the capital of 
Bangladesh. The district is a part of the Himalayan plain land and the state of 
India lies on its west and north side. This district has 5 upazilas (sub-district). 
Subjects were recruited from all upazilas by following simple random 
procedure.  
 
 
 
 
 
 
 
 
 
 
 
3.2 Study Design 
The study was a population based general cross-sectional study which was 
ultimately focused on the prevalence and determinants of diabetes mellitus 
and retinopathy among the rural population of Bangladesh. This 
epidemiological survey was conducted through screening in camp settings to 
Camp site 2 
Camp site 1 
Camp site 3 
 29
detect diabetes and retinopathy. Three camps were organized in 3 different 
places of Thakurgaon district.  
3.3 Study Population 
This study was a part of an ongoing large epidemiologic study of Bangladesh 
Diabetic Somity, involving a representative population of Thakurgaon 
district. The study population was both male and female adults aged ≥ 25 
years who were the residents of this district.  
3.4 Sample Size Calculation 
As this study was only a part of a continuing large epidemiologic study, to 
determine the required sample size for this part of study, the formula: n = 
PQ/d2 was used. Where P for prevalence (of DM + Pre DM) from the previous 
study, i.e. 0.14 (14%); Q = 1 – P, i.e. 0.86 and d = allowable error of known 
prevalence i.e. 0.085 × 0.14. Thus the sample size, n = 850. But a total of 836 
subjects participated in the study. The sample size calculation was done for 
predicting the prevalence of diabetes mellitus in Bangladeshi population. This 
subset of population was also investigated to estimate the prevalence of 
retinopathy among diabetes and non diabetes population and explore the 
associated risk factors for developing retinopathy. Following a simple random 
procedure 1000 individuals aged ≥25 years were identified to participate in 
this study. Among them 836 individuals agreed to participate and were 
investigated in the present study.  
3.5 Study Period 
The present study took about 6 months for collecting data. Three camps were 
organized in 3 different places of Thakurgaon district by Thakurgaon 
Swasthoseba Hospital within this time period. The first camp was held on 
June 2008, second camp on August 2008 and the last camp on December 2008. 
Each camp continued for two days.  
3.6 Inclusion Criteria  
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Both men and women ≥25 years of age who are the inhabitants of this district 
and are willing to participate voluntarily and comply with the instruction of 
the study e.g. overnight fasting, was considered eligible for the study.  
3.7 Exclusion Criteria  
People who were not qualified by inclusion criteria were excluded from the 
study. Pregnant women and physically or mentally disabled persons unable 
to follow simple questions were excluded.  
3.8 Survey Procedures 
Sixteen field assistants were recruited from the local community and trained 
for the field work which included sample selections, organizing the screening 
camps, collection of data by reviewing the questionnaire and delivering the 
results to the participants. Seven days of training were provided to the 
assistants for selection process, interview and data collection prior to the 
commencement of the study. Each trainee was evaluated before he or she was 
allowed to participate in the study. The field assistants listed all the adults 
aged ≥25 years from each area and identified the required number of subjects 
following simple random procedure.  
All the individuals selected for the study were given an identification 
number. The field assistants approached the potential participants by an 
information letter and a respond document. Participants were informed of the 
purpose and the procedure of the study and they were requested to attend the 
screening camps in the morning on a pre-arranged date after an overnight fast 
of at least 8-10 hours. Each and every subject was made aware and was 
explained the necessity of the fasting state of a minimum 8-10 hr prior to the 
test. On arrival at the pre scheduled time (7.30 am to 8.30 am) on the 
appointed day, confirmation of the fasting state was verified once again from 
each participant by asking the fasting state. After receiving the consent 
general registration of the participant was initiated and the whole 
investigation procedure was started. Venous blood and urine sample were 
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collected from each participant at their fasting state and after 2 hours break 
venous blood sample was again collected from them. 
During the 2 hr waiting period the participants were interviewed for some 
general information through the preseted questionnaire and were measured 
some biophysical parameters which include anthropometric (height, weight, 
waist circumference and hip circumference) and blood pressure 
measurements. Further comprehensive ocular examinations were performed 
on each subject by trained technical assistants and ophthalmologists.  
3.9 Interviewer Administered Questionnaire  
The preseted questionnaire was composed of some general information; like 
the demographic and socioeconomic information, including name, sex, age, 
education, occupation and economic status. The participants were asked for 
their 1st degree family history of diabetes, associated complications of 
diabetes, if any, (nephropathy, neuropathy, hypertension, hyperlipidaemia, 
coronary artery diseases) and information related to their own medical 
history of obesity, hypertension, diabetes and associated complications of 
diabetes. They were also asked for the ocular history which includes details of 
first and last eye examination, nature of present eye complaint or any ocular 
surgery. 
3.10 Clinical Parameters 
With proper aseptic precaution, initial 8 ml of venous blood and urine sample 
were collected from each participant. Fasting blood glucose (FBG), lipid 
profile (triglyceride, total cholesterol, high density lipoprotein and low 
density lipoprotein), serum creatinine and glycosylated hemoglobin (HbA1c) 
were determined from fasting blood sample and albumin creatinine ratio 
(ACR) was measured from urine sample. All subjects other than those with 
known diabetes (n=22) were then given a 75-g oral glucose solution (75-g oral 
glucose load dissolved in 500 ml of water) to drink. Another 3 ml of venous 
blood was collected after 2 hours to determine 2 hr post oral glucose tolerance 
test (OGTT). 
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After collecting the blood and urine sample it was centrifuged on the site 
within 3 hours to separate plasma. All samples were then refrigerated and 
stored at -200C until laboratory assays was done. Fasting blood glucose (FBG) 
and oral glucose tolerance test (OGTT) were analyzed by glucose oxidase 
method (Randox, UK) for the diagnosis of diabetes mellitus. Lipid profile 
includes total cholesterol (TC), high-density lipoprotein (HDL), low-density 
lipoprotein (LDL) and triglycerides (TG), which were measured by enzymatic 
technique. Glycosylated hemoglobin (HbA1c) was measured by high-
performance liquid chromatography (HPLC). 
3.11 Anthropometrical Measurement 
Anthropometric measurements included height, weight, waist circumference 
and hip circumference. The measurements were taken with light clothes 
without shoes. Height was measured by using a portable, locally 
manufactured, stadiometer, standing upright on a flat surface without shoes 
to the nearest 0.1 cm. Body weight was measured while wearing light clothes 
by an adjusted scale and recorded to the nearest 0.1 kg. Body mass index 
(BMI) was calculated by the formula: weight in kilograms divided by height 
in meters squared. Waist circumference was measured at 1 cm above the level 
of navel at minimal respiration and hip circumference was measured at the 
level of maximum posterior extension of the buttocks by placing a flexible 
plastic tape horizontally with light clothes. Both circumferences were 
recorded to the nearest 0.1 cm. Two readings of height, weight, waist 
circumference and hip circumference were recorded and the mean of the two 
was taken as the final reading. Asian BMI criteria were used to identify 
overweight and obese in this population (P1: 16). Five categories of BMI were 
identified here for presenting the data. Individuals with BMI below 18.49 
kg/m2 classified as underweight, healthy weight (BMI 18.5-22.99 kg/m2), 
overweight (BMI 23.0-24.99 kg/m2), obese I (BMI 25.0-29.99 kg/m2) and 
obese II (BMI over 30.0 kg/m2)), respectively.Abdominal obesity was 
evaluated by waist/hip ratio, with android and gynaecoid cut off points taken 
at 0.8 and 0.9 for females and males respectively (P1: 17). 
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3.12 Blood Pressure Measurement 
Blood pressure was taken after administration of the questionnaire. To reduce 
the variation, subjects rested for at least 10 minutes before the BP was 
recorded. The pressure was measured in sitting position on the right arm 
using normal cuffs for adults fitted with a standard mercury 
sphygmomanometer, placing the stethoscope bell lightly over the brachial 
artery. BP was usually recorded to the nearest 2 mm Hg from the top of the 
mercury meniscus. Two readings were taken 5 minutes apart, and the mean 
of the two was taken as the final blood pressure reading of the individual. 
Hypertension was defined as a systolic blood pressure (SBP) of ≥ 140 mm Hg 
and/or diastolic blood pressure (DBP) of ≥ 90 mm Hg (P1: 18). 
3.13 Ophthalmologic Examinations 
All the participants were gone through a complete ocular examination on that 
prearranged day by trained ophthalmologists. Visual acuity was recorded 
with an illuminated Snellen chart. The presenting and best corrected visual 
acuity was documented separately for each eye. Intraocular pressure 
measurement was performed with Schiotz indentation tonometer (Schiotz, 
John Weiss & Son Ltd, London, UK). Slit lamp was used for anterior segment 
evaluation including the depth of anterior chamber and rubeosis irids with 
diluted pupils. Fundus photography was operating with a digital camera 
(Super 66 equipped with stereo fundus lens). Dilated fundus evaluation was 
done with binocular indirect opthalmoscope (Keeler Instrument Inc, PA, 
USA). The photographs were taken in a dark room after a 5 minute 
adaptation period to allow the pupils to dilate to some extent and were 
analyzed by two ophthalmologist specialized in retinal diseases. World 
Health Organization recommended definitions of retinopathy, vision, and 
visual disability (ICD 10) was used (P2: 25). Among 836 participants 45 were 
identified with retinopathy and were referred to the Thakurgaon Swasthoseba 
Hospital, the Health Care Center of the Bangladesh Diabetic Somity for 
further treatment and follow-up.  
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3.14 Diagnosis Criteria for Diabetes 
After estimation of fasting blood glucose (FBG) and oral glucose tolerance test 
(OGTT), the participants were classified into non diabetes, diabetes mellitus, 
IFG (impaired fasting glucose) and IGT (impaired glucose tolerance), 
according to the recommendation of the World Health Organization Expert 
Committee (P1: 18).  Subjects were defined as having diabetes mellitus (n = 
60) based on their fasting blood glucose levels ≥ 7.0 mmol/l or 2 hr post 
glucose levels ≥11.1 mmol/l or both. IFG was defined when FBG values were 
between 6.1-7.0 mmol/l and OGTT <7.8 mmol/l. IGT was defined when FBG 
<7.0 mmol/l and OGTT values were between 7.8-11.1 mmol/l. IFG and IGT 
subjects were together called pre diabetes (n = 54). Thirteen retinopathy cases 
were identified from the diabetic subjects and 7 were from pre diabetic 
subjects. The rest 25 retinopathy cases are non diabetic subjects. 
3.15 Criteria for Other Variables 
According to the ADA recommendation (P1: 35) the cut of value of other 
variables like, total cholesterol (<200 mg/dl), triglyceride (<150 mg/dl), LDL 
(<100 mg/dl), HDL (for male >50 mg/dl and for female >40 mg/dl), serum 
creatinine (for male <1.4 mg/dl and for female <1.2 mg/dl) and urine 
albumin creatinine ratio (<30 mg/g) was used for data analysis. 
3.16 Ethical Consideration 
All necessary ethical and administrative approvals were obtained from the 
appropriate authorities before commencement of the study. The protocol was 
approved by the Norwegian Ethical Committee for Medical Research and the 
National Ethical Committee of Bangladesh. Administrative clearance was 
obtained from Bangladesh Ministry of Public Health, the District Medical 
Officer and local official institutes.  
Permission to conduct this study was also obtained from the target group. All 
participants were provided with a detailed information letter about the study 
objectives, procedures and the risk and benefits involved. This information 
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was explained sufficiently to the participants who were treated with respect 
for their dignity. They had an opportunity to discuss with the study team if 
they required further information and clarification. All subjects selected to 
participate in the study, signed an informed consent form prior to 
commencing any study procedure. However, the participants who were 
illiterate gave verbal consent and the witness signed on the document on 
behalf of the participant. They were informed of their rights to withdraw from 
the study at any stage of the study without giving any notification of reasons.  
The project was carried out in accordance with the guidelines in the Helsinki 
Declaration. The participants were reassured about the confidentiality of data. 
The questionnaires and laboratory documents were kept securely. Folding 
screens were used to isolate the subjects. Male and female participants were 
stayed in different separate rooms while conducting anthropometric and 
clinical examinations. In consideration of safety for both subjects and doctors 
disposable hypodermic syringes, gloves and other necessities were used while 
taking blood sample. The blood and urine specimen were frozen and stored 
well. All of the test on blood and urine were only done for research purpose. 
Other unrelated persons had no access to data files.  
The written results of medical examination were distributed and explained to 
the participants through Thakurgaon Swasthoseba Hospital, the Health Care 
Center of the Bangladesh Diabetic Somity. They were free to discuss their test 
reports with the doctors. They were encouraged to raise health questions and 
the questions were answered individually. Clinical suggestions were 
delivered if needed. Anyway, the subjects and the target population were 
benefited from the research potentially, although our project didn’t provide 
intervention or medication directly. The identified cases for diabetes, trend to 
diabetes and retinopathy were referred to the Thakurgaon Swasthoseba 
Hospital for follow up and further treatment.   
 
 
 36
3.17 Data Analysis 
The data was entered in the pre-designed Microsoft office excel format which 
was imported later into the statistical software SPSS. The prevalence rates of 
diabetes and retinopathy were determined by simple percentages. Statistical 
comparisons between categorical variables were made by using χ2 test and 
comparisons between continuous variables were made by using independent 
sample t test. The odds ratio (OR) with 95% confidence interval (CI) for risk 
factors was calculated assuming the least prevalence of clinically relevant 
criteria as a reference value. Multiple logistic regression were performed to 
quantify the individual effect of predictor variables and to adjust for potential 
confounding factors. All P-values presented are two-tailed.  The statistical 
tests were considered significant at a level ≤5% (≤0.05). All the statistical 
analysis were performed using SPSS 16 software. 
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4  RESULTS 
4.1 Demographic and Socio-economic Characteristics of the study subjects 
(Table 1) 
In this cross sectional study a total of 836 participants were registered to 
attend all the activities of the camp. The mean (±SD) age (in years) of the 
participants was 46 (±12) years. All participants were divided into 3 age 
groups with 15 
Table 1: Demographic and Socio-economic Characteristics of the study 
subjects 
Variables Frequency Mean±SD/Percentage 
Total Participants 836 46.0(±12) 
Male Participants 468 46.0(±12) Mean Age 
Female Participants 368 45.0(±11) 
25-40yrs 326 39 
41-55yrs 300 36 
 
Age 
> 55 yrs 210 25 
Male 468 56 
Gender 
Female 368 44 
Illiterate 284 34 
Primary 276 33 
SSC 184 22 
HSC 59 7 
BSc 25 3 
Education 
MSc 8 1 
Farmer and day labor 284 34 
Service holder 84 10 
Businessmen 108 13 
Housewives 293 35 
Occupation 
Retirement 67 8 
Poorest of the poor 192 23 
Poor  359 43 
Lower middle class 235 28 
Socio-Economic 
Status 
 
Middle class 50 6 
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years age interval. Among the participants 326 (39%) participants were 
between 25 to 40 years, 300 (36%) participants were between 41 to 55 years 
and 210 (25%) were above 55 years of age. Among the 836 participants 56% 
(n=468) were male and 44% (n=368) were female participants. Females being 
younger (mean±SD, 45.0±11) compared to male (mean±SD, 46.0±12) subjects. 
A major portion of the participants were illiterate (34%) and below primary 
level (33%). SSC, HSC, Degree, and masters’ level participants were 22%, 7%, 
3% and 1% accordingly. Major number of participants was housewives (35%). 
Among the others farmers and day labors were 34%, service holders 10%, 
small businessmen 13% and retired personnel 8%. Among the participants 
23% were poorest of the poor, poor were 43%, Lower middle class 28% and 
middle class 6%.  
4.2 Anthropometric and clinical characteristics of the study subjects (Table 
2)  
General anthropometric and clinical characteristics of the participants were 
presented by gender with 15 years age interval. There were no differences in 
BMI between male and female participants in all age strata. However the 
mean BMI was 22.2 and 21.9 for the male and female participants, 
respectively. Mean BMI was increased according to the age group for both 
males and females. This picture is also reflected in the assessment of other 
parameters except for LDL. In younger age group there were significant 
differences in systolic blood pressure, diastolic blood pressure, triglyceride 
and total cholesterol between male and female participants. But it is not 
reflected in other age groups. A superior agreement was observed between 
FBG and OGTT (Kappa value 0.86) among the study participants (data has 
not shown). 
 
 
 
 
 39
Table 2:  Anthropometric and clinical characteristics of the study subjects 
25-40 yrs 41-55 yrs above 55 yrs  
Variables Male 
(n=162) 
Female 
(n=164) 
P for 
differ
ence 
Male 
(n=172) 
Female 
(n=128) 
P for 
differ
ence 
Male 
(n=134) 
Female 
(n=76) 
P for 
differ
ence 
BMI (kg/m2) 21.4±3.2 21.6±3.5 0.650 22.3±3.6 21.8±3.7 0.141 22.9±4.2 22.5±4.6 0.585 
WHR* 0.89±0.06 0.87±0.07 0.018 0.92±0.07 0.88±0.07 0.001 0.93±0.07 0.92±0.08 0.122 
SBP (mmHg) 117.7±15.4 113.4±15.8 0.014 119.7±16.8 121.3±22.6 0.490 123.7±19.1 125.1±20.1 0.418 
DBP (mmHg) 77.5±10.8 74.6±11.6 0.029 78.2±11.4 80.3±15.5 0.253 78.7±12.9 81.2±15.0 0.196 
FBG (mmol/l) 5.03±1.7 5.05±1.8 0.913 5.1±1.5 5.3±2.1 0.277 5.2±1.4 5.7±2.3 0.142 
AG (mmol/l) 5.9±2.3 6.2±2.6 0.209 6.1±2.7 6.4±3.1 0.325 6.4±3.0 7.3±4.5 0.146 
HbA1c (%) 4.9±1.2 5.01±1.1 0.480 5.1±1.3 5.1±1.2 0.996 5.4±1.4 5.8±1.9 0.172 
S Creatinine 
(mg/dl) * 
1.12±0.23 1.03±0.21 0.001 1.24±0.33 1.16±0.26 0.050 1.40±0.40 1.31±0.43 0.062 
Triglyceride 
(mg/dl) 
156.4±65.3 135.9±54.7 0.002 156.6±62.1 155.7±56.9 0.936 162.2±65.3 163.4±71.9 0.912 
Cholesterol 
(mg/dl) 
187.3±32.4 178.0±32.9 0.013 189.5±40.6 192.9±35.2 0.642 190.8±40.3 198.3±40.5 0.068 
HDL (mg/dl) * 36.8±8.4 34.1±8.3 0.010 37.8±11.1 34.8±7.4 0.002 38.0±11.2 37.3±8.6 0.615 
LDL (mg/dl) 119.7±29.6 116.5±30 0.332 127.1±37.6 126.2±33.6 0.702 118.2±37.1 124.1±39.4 0.310 
UACR (mg/g) 13.7±6.2 13.9±5.8 0.996 13.9±6.7 14.7±6.9 0.470 18.3±7.9 18.7±8.4 0.824 
Data are presented as mean±SD; independent t- test was done as a test of significance.  
Abbreviations: BMI, Body mass index; WHR, Waist hip ratio; SBP, Systolic blood pressure; DBP, 
Diastolic blood pressure; FBG, Fasting blood glucose; AG, After 2 hr glucose load; HbA1c, 
Glycosylated hemoglobin; HDL, High density lipoprotein; LDL, Low density lipoprotein; UACR, 
Urine albumin creatinine ratio 
* Data are coded with reference value separately for male and female and then analyzed together. 
 
4.3 Prevalence of diabetes, prediabetes and retinopathy among the study 
population (Table 3) 
The overall prevalence of diabetes was 7.2%, prediabetes (both IGT & IFG) 
was 6.5% and retinopathy was 5.4%. Prevalence of diabetes, prediabetes and 
retinopathy increased with increasing age both for males and females. 
Though non-significant, females had higher prevalence of diabetes, 
prediabetes and retinopathy compared with males in all age groups. The 
difference in prevalence of diabetes and retinopathy by sex widened in the 
older age group (>55 years). But for pre diabetes, the difference in prevalence 
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by sex was wider in the younger age group (25-40 years), while the difference 
was very narrow in the older age group (>55 years). 
Table 3: Prevalence rate of diabetes and prediabetes and retinopathy by 
gender distribution 
Number of cases Prevalence per 100 Groups Total 
Male 
Total 
Female 
Male Female Male Female 
Total 
prevalence 
(%) 
P for 
difference 
 
Diabetes 468 368 32 28 6.8 7.6 7.2 0.668 
Prediabetes 468 368 26 28 5.5 7.6 6.5 0.231 
Retinopathy 468 368 23 22 4.9 5.9 5.4 0.499 
 
4.4 Prevalence of retinopathy according to glucose metabolism category 
(Table 4) 
In the present study we found that the prevalence of retinopathy was 21.6% 
among the diabetic subjects (DM), 13% among the prediabetic subjects (Pre 
DM) and 3.5% among the nondiabetic subjects (NGM), respectively. Males 
had higher prevalence of retinopathy compared with females in diabetes 
group. On the contrary, females had higher prevalence of retinopathy 
compared with males in prediabetes and nondiabetes group. 
Table 4: Prevalence rate of retinopathy by glucose metabolism category 
Retinopathy cases Prevalence per 100 Glucose 
Metabolism 
Category 
Total 
Male 
Total 
Female 
Male Female Male Female 
Total 
prevalence 
(%) 
P for 
difference 
 
DM 32 28 9 4 28.1 14.3 21.6 0.094 
Pre DM 26 28 3 4 11.5 14.3 13.0 0.764 
NGM 410 312 11 14 2.7 4.5 3.5 0.189 
Abbreviations: DM, Diabetes Mellitus; Pre DM, Pre Diabetes Mellitus; NGM, Normal Glucose 
Metabolism.  
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4.5 Baseline characteristics of diabetic, pre diabetic and non diabetic people 
The characteristics were compared between subjects with diabetes (n=60) & 
non diabetes (n=722), pre diabetes (n=54) & non diabetes (n=722) and diabetes 
(n=60) & pre diabetes (n=54). The subjects with diabetes were significantly 
older with higher BMI, WHR, blood pressure, serum glucose (fasting and 2 hr 
after glucose), HbA1c, serum creatinine, triglyceride, total cholesterol, LDL, 
UACR and significantly lower HDL compared to subjects with non diabetes. 
Although non significant, the subjects with pre diabetes were older than non 
diabetes subjects. The comparison of other characteristics between pre 
diabetes and non diabetes subjects yielded similar results. The subjects with 
diabetes had significantly higher WHR, serum glucose (fasting and 2 hr after 
glucose), HbA1c, serum creatinine and triglyceride compared to subjects with 
pre diabetes. Although non significant, diabetes subjects had higher age, BMI, 
blood pressure, total cholesterol, HDL, UACR and lower LDL compared to 
subjects with pre diabetes. 
4.6 Baseline characteristics of people with retinopathy and without 
retinopathy in diabetes and non diabetes group 
Forty five individuals were found to have retinopathy among 836 participants 
which included diabetic, prediabetic and nondiabetic population. The 
baseline characteristics were compared between subjects with and without 
retinopathy. The subjects with retinopathy were significantly older with 
higher BMI, WHR, blood pressure, serum glucose (fasting and 2 hr after 
glucose), HbA1c, serum creatinine, triglyceride, total cholesterol, LDL, UACR 
compared to subjects without retinopathy. Although non significant subjects 
who developed retinopathy had lower HDL compared to subjects without 
retinopathy. 
Diabetic subjects (n=60), with diabetic retinopathy had significantly higher 
age, BMI, diastolic blood pressure, HbA1c, serum creatinine, total cholesterol, 
LDL and UACR compared to subjects without retinopathy. However, higher 
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WHR, systolic blood pressure, serum glucose (fasting and 2 hr after glucose), 
triglyceride and low level of HDL were not found to be significantly 
associated with increasing the prevalence of retinopathy among the diabetic 
subjects. On the contrary, age, WHR, blood pressure, serum fasting glucose, 
HbA1c, serum creatinine, total cholesterol, LDL and UACR were significantly 
higher in individuals with retinopathy among the non diabetic individuals 
(n=776). Subjects with diabetic retinopathy were significantly older with 
higher BMI, WHR, diastolic blood pressure, serum glucose (fasting and 2 hr 
after glucose), HbA1c, serum creatinine, triglyceride, total cholesterol and 
LDL compared to those with retinopathy but without diabetes. 
4.7 Associated risk factors for developing Diabetes among the study 
population  
We used logistic regression to quantify the individual effects of age, sex, BMI, 
WHR, SBP, DBP, S Creatinine, Lipids and UACR with diabetes. Age, BMI, 
WHR, SBP, DBP, S Creatinine, triglyceride, total cholesterol and UACR were 
found to be significant risk factors for the occurrence of diabetes mellitus in 
the univariate model. After adjusting for potential confounders in the 
multivariate model by using all variables BMI, WHR, S Creatinine, 
triglyceride, total cholesterol and UACR remained as significant independent 
risk indicators for the occurrence of diabetes in this population. BMI >23.0 
showed to be exceedingly risky state for the occurrence of diabetes. The risk 
for diabetes was almost 2-fold or sometimes more than 2-fold higher in 
subjects with BMI >23.0 kg/m2, high WHR both for male and female, high 
serum creatinine for both sex, triglyceride >150 mg/dl, cholesterol >200 
mg/dl and UACR >30 mg/g. 
4.8 Associated risk factors for developing retinopathy among the study 
population  
We used logistic regression to quantify the individual effects of age, sex, 
glucose metabolism category, BMI, WHR, SBP, DBP, hypertension, HbA1c, S 
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Creatinine, Lipids and UACR with diabetes. Age, glucose metabolism 
category, BMI, SBP, DBP, hypertension, HbA1c, S Creatinine, triglyceride, 
total cholesterol and UACR were found to be significant risk factors for the 
occurrence of retinopathy in the univariate model. After adjusting for 
potential confounders in the multivariate model by using all variables in the 
model age, DM, BMI, SBP, DBP, hypertension, HbA1c, S Creatinine, total 
cholesterol and UACR remained as significant independent risk indicators for 
the occurrence of retinopathy in this population. The risk for retinopathy was 
almost 2-fold in subjects who were above 40 years with fasting glucose of ≥6.1 
mmol/l, BMI >25.0 kg/m2, hypertensive, increased HbA1c level of above 
5.3%, high serum creatinine for both sex, cholesterol >200 mg/dl and UACR 
>30 mg/g. 
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5  DISCUSSION 
5.1 Main Findings 
The present study addressed the prevalence and its associated risk factors of 
diabetes and retinopathy in a rural population in Bangladesh. The prevalence 
of diabetes was found to be 7.2% which is comparable to the recent rural 
studies (P1: 6, 7, 9), but significantly higher than the studies conducted in 
early 2000s (P1: 3, 4, 5). However, moderate but steady rise in the prevalence 
of pre diabetes (6.5%) was observed compared to a recent published data (P1: 
3), but rather a lower prevalence compared to another study (P1: 6). Data on 
the rising trend of diabetes in Bangladesh were based on the comparison of 
data collected from different parts of the country at different times and had 
applied different procedures, other than one (P1: 4). Therefore, it is difficult to 
make a scientific comprehension of the rising trend of diabetes. To compare 
secular trends, it would be more accurate to document the prevalence of 
diabetes within the same region applying the identical procedure. 
The prevalence of diabetes documented in this study was comparatively 
higher than the prevalence found in rural China (5.6%), but more related to 
that of rural India (6.3%) and was equal to that of rural population in Turkey 
(7.2%) (P1: 19, 20, 21). However, the observed prevalence rate of diabetes in 
this report is lower than the prevalence found in rural Pakistan (11.1%) (P1: 
22). But the direct comparisons of prevalence rates are challenging owing to 
differential methodologies applied and diverse characteristics of the 
population.  
Several studies showed that urbanization, economic development and 
affluent lifestyle are causing high prevalence of DM even in the developing 
countries (P1: 23, 24, 25). The rural Bangladeshi population is undergoing 
lifestyle transition due to socio-economic growth, which is associated with 
this increased rate in the prevalence of diabetes in rural Bangladesh. But BMI 
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in this population remain low. Therefore, it would be difficult to ascribe the 
increased prevalence only due to higher calorie intake as a consequence of 
improved socio-economic condition. Rather higher pre diabetes in a lean 
population may also indicate genetically susceptible population, who may 
convert to diabetes with a much lower change in obesity, although the BMI 
may remain low. Thus there could be a rapid progression from the normal 
state through pre diabetes to diabetes, which could imply a rapid increase in 
the diabetes epidemic or a worsening diabetogenic environment. Prospective 
studies are required to assess the exact changes occurring with regard to the 
diabetes epidemic in Bangladesh. 
As obesity is an established risk factor for diabetes, we have observed an 
important association of both general obesity and central obesity with 
diabetes. It is of interest to note that general obesity was found to have more 
than 2-fold higher risk for developing diabetes in subjects with BMI >23.0 
kg/m2 in the present study. We had previously noted that the risk of diabetes 
occurred at a lower BMI threshold (<23 kg/m2) in Asian Indians (P1: 28). 
Data from recent studies in Bangladesh did not show any significant 
association between BMI and diabetes (P1: 3, 5). However, in other studies 
higher BMI (>25.0 kg/m2) was found as an important predictor for occurrence 
of type 2 diabetes (P1: 4, 7, 9). But the population from previous studies 
showed lean BMI. A study in India (P1: 29) found the prevalence of diabetes 
was high even though the rates of obesity were low among the Indian urban 
and rural population. WHR also appeared to be a significant risk factor for 
diabetes in the multivariate analysis. The association between WHR and DM 
was evident in the earlier studies in Bangladesh (P1: 7, 30). We have also 
noticed that the risk of diabetes occurred by central adiposity along with 
lower BMI threshold in Asian Indians (P1: 28). We have observed central 
obesity even among people with normal BMI in our population. Therefore, 
the transition in lifestyle occurring in the rural population seemed to produce 
rapid adverse changes favoring diabetogenesis. 
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Another interesting observation in this present study was that the lipids 
(triglyceride and total cholesterol) showed as strong risk factor for developing 
diabetes in rural population of Bangladesh. But this significant association 
was conflicting with earlier rural study (P1: 6). Surprising fact of this study 
was that systolic and diastolic hypertension was significantly associated with 
the occurrence of diabetes mellitus in the univariate model but non significant 
marginal risky state was observed in the multivariate logistic regression. Only 
one earlier study among rural subjects showed a significant association with 
both systolic and diastolic hypertension and higher glycemic status (P1: 31). 
Other recent studies observed significant association only between systolic 
hypertension and diabetes (P1: 4, 5). The inconsistent association between 
diabetes and hypertension has been previously reported in many ethnic 
groups and the role of hyperglycemia in determining blood pressure for 
ethnic differences are evident from these studies (P1: 32-34).  
Very few data are available on the extent of urine albumin-creatinine ratio 
(UACR) as a strong predictor for the occurrence of diabetes mellitus. But there 
has been considerable focus on the concept that, it is an important marker for 
more pronounced diabetic vascular complications like retinopathy as well as 
nephropathy. In the present study we tried to observe the association between 
UACR and diabetes as we don’t have any data regarding this. Here UACR 
was found as a significant risk factor for developing DM in this rural 
population of Bangladesh. The indices of obesity (increased BMI and WHR), 
hyperlipidemia (increased triglyceride and cholesterol) and urine ACR may at 
least in part explain the rising trend of diabetes mellitus in this rural 
population of Bangladesh. 
In this study prevalence of retinopathy was found 21.6% (95% CI 11.2-32.0) 
among the diabetic subjects, 13% (95% CI 3.4-22.6) among the prediabetic 
subjects and 3.5% (95% CI 2.2-4.8) among the nondiabetic subjects, 
respectively. The age standardized prevalence of retinopathy was calculated 
at 5.4% (95% CI 3.9-6.9) among 836 people aged 25 years and older that were 
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examined in the course of this study. We have found a higher prevalence of 
DM in this study population and the prevalence of retinopathy was increased 
in the subjects with increasing deciles of glycemic level. The prevalence rate of 
retinopathy in different glucose metabolism categories documented in this 
study was comparatively similar to other two recent European studies. A 
population based Hoorn study with cohort design found the incidence of 
retinopathy as 17.5% in DM, 13.6% in IGT and 7.3% in NGM subjects (P2: 29). 
Another cross-sectional study done in Finland estimated the prevalence of 
retinopathy as 25% in DM, 2% in IGT and 3% in normoglycemic or NGM 
subjects (P2: 30). Early epidemiological evidences showed that the prevalence 
of retinopathy is increased in the subjects whose glycemic values were in the 
highest two or three deciles in population with a high prevalence of diabetes 
(P2: 31, 32). As the consequences of increasing number of diabetic subjects, the 
number of DM with its associated complications like retinopathy would also 
rise in Bangladesh. Moreover, a high prevalence of retinopathy was found in 
this study in normoglycemic subjects, as in the other studies (P2: 31-33). As 
there is no previous study in Bangladesh, therefore, it is difficult to make a 
scientific comprehension of the rising trend of retinopathy.  
In this study population, retinopathy tended to be associated with several 
factors such as, increased age, glucose metabolism category, higher BMI, 
hypertension, HbA1c level, serum creatinine, total cholesterol and UACR. In 
contrast to other studies (P2: 29, 35), however, the prevalence of retinopathy 
in our study had a significant tendency to get higher with increasing age. Our 
study confirmed the well known positive association between hyperglycemic 
status and retinopathy. This result in accordance with those of previous 
studies (P2: 12-14, 39), have shown retinopathy to be associated with glucose 
metabolism status or with high fasting blood glucose levels. There is strong 
evidence to suggest that the development and progression of retinopathy is 
influenced by glycosylated hemoglobin (HbA1c) level (P2: 40-44) which was 
also reflected in our study.  
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BMI, the indicator for general obesity seemed to indicate a high risk of 
developing retinopathy in this population. In line with our study, a positive 
association between BMI and retinopathy was found in few studies (P2: 40, 
45, 46, 47) that included diabetic subjects. WHR, the indicator for central 
obesity was also an independent risk factor for developing retinopathy in 
diabetic subjects (P2: 42, 44) as well as in nondiabetic subjects (P2: 29). After 
adjustment for potential confounders in multivariate model WHR did not 
remain as significant independent risk indicators for the occurrence of 
retinopathy in this population. The estimated risk for developing retinopathy 
in individuals with hypertension was almost 2 times as high as in individuals 
without hypertension, which remained after adjustment for possible 
confounders. This is in line with previous findings of incident retinopathy in 
studies (P2: 35, 43, 45, 48) of diabetic subjects and in the 2 other studies (P2: 
49, 50) that included nondiabetic individuals. The present study did not find a 
statistically significant association between serum triglyceride, HDL 
cholesterol and LDL cholesterol and occurrence of retinopathy. Association 
between cholesterol and prevalence of retinopathy, although not always 
statistically significant in multivariate risk models, were described in several 
studies (P2: 42, 44, 45, 51) that included diabetes subjects. Cross-sectional data 
(P2: 52, 53) have shown that hard exudates in particular are associated with 
elevated cholesterol levels. In the present study risk for retinopathy in 
subjects with high level of cholesterol was more than 2 times as high as in 
subjects with normal cholesterol level. Cross-sectional (P2: 37) and 
longitudinal studies (P2: 54, 55) report a relationship between 
microalbuminuria and retinopathy. Elevated serum creatinine and urine 
albumin creatinine ratio were found as significant risk indicators for 
developing retinopathy in this population. The present findings of the 
combination of these risk indicators for predicting retinopathy may suggest 
that insulin resistance or associated factors are implicated in the pathogenesis 
of retinopathy. 
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5.2 Methodological Considerations 
5.2.1 The strength of the study 
The main strength of the current study was its study design. A population 
based study design was applied which ultimately focused on the prevalence 
and associated risk factors of diabetes mellitus and retinopathy among the 
rural Bangladeshi population. Population based studies are the most 
appropriate and useful approach where samples from a representative 
population are tested.  Therefore the data represented the total population. 
Several hospital based studies have been done focusing on the magnitude of 
diabetes and retinopathy but the data available from hospital or clinic based 
studies which have several biases including selection bias and referral bias. 
Thus, it may not have representativeness and it only provides rough estimates 
of the disease prevalence with large percentages remaining undetected. 
Therefore to provide a baseline data on the prevalence of diabetes and 
retinopathy as well as their associated risk factors in a rural Bangladeshi 
population, we carried out a population based study. The result of the current 
study may lay the foundation to develop policies necessary to cope with the 
challenges of the disease burden. 
Other strength of this study lies in the quality control of different 
measurements for anthropometric, blood pressure, clinical parameters and 
ocular examinations. Well trained investigators were provided in the field to 
assure that the standard was up to date. Investigators were asked to take the 
measurement of biophysical parameters as accurate as possible. Biophysical 
parameters, which included anthropometric (BMI and WHR) and blood 
pressure, measured by well trained investigators, which made the result more 
reliable than self reported results. Two readings of height, weight, waist 
circumference and hip circumference were recorded and the mean of the two 
was taken as the final reading of these parameters of the individual and used 
for analysis. 
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After collecting the blood and urine samples with proper aseptic precaution 
by experienced professionals, they were properly centrifuged on the site 
within the specific time period. All samples were then refrigerated and stored 
appropriately at -200C until laboratory assays were done. The clinical 
parameters from blood and urine specimen were analysed in the laboratory at 
BIRDEM, which is known to be one of the best laboratories in Bangladesh. 
Clinical sensitivity and specificity for the selection of different methods for 
different variables were considered. Reference serum was used for internal 
quality control everyday. All ocular examinations were done by trained 
technical assistants and ophthalmologists. 
Cross checking and validate action forms were used as quality measure for 
data entry helped in the consistency of the results. The sample size calculation 
was done for predicting the prevalence of diabetes mellitus in Bangladeshi 
population. This sample (836) was not specifically calculated to estimate the 
prevalence of retinopathy among diabetes and non diabetes population and 
to explore the associated risk factors for developing retinopathy; however, the 
sample size calculation, met the requirement for analysis. We detected a high 
prevalence of diabetes, pre diabetes, as well as retinopathy in diabetes and 
non diabetes population in rural Bangladesh. Most potential confounding 
factors like age, gender, body mass index, hypertension etc were carefully 
controlled using multivariate analysis (logistic regression).  
As no single population based study has yet been done in Bangladeshi 
general population to estimate the magnitude of the problem of retinopathy, 
this result will be use as a reference data. The absence of reliable population 
based epidemiological data on retinopathy in Bangladesh is a serious 
impediment to the effective national planning of eye care programmes. 
Finally, as BIRDEM and its sister organizations all in well known of this 
population, we recruited local volunteers to serve in the camps by making 
sure that the participants comply with the dietary and other advices prior to 
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test for fasting blood glucose, thus increasing the reliability of the data and 
results.     
5.2.2 The validity of the study  
Validity refers to whether one is able to measure what he/she intends to 
measure. It can be divided into internal and external validity. Internal validity 
is an estimate of how much the measurement is based on clean and safe 
experimental techniques, which means that it is related to the instruments 
used. The clinical parameters which included both blood and urine specimen, 
were analysed in the laboratory at BIRDEM, which is known to be one of the 
best laboratories in Bangladesh. All the ocular examinations were done by the 
latest ophthalmic equipment. This increases the internal validity of the study. 
The strong point of this study was that the diagnosis of retinopathy was based 
on retinal photograph using fundus camera through dilated pupils, instead of 
nonmydriatic photograph. It has been argued that the use of nonmydriatic 
camera results in a moderately high frequency of ungradable photograph, 
especially in the presence of media opacities. Accuracy of the anthropometric 
measurements by the quality staffs and blood pressure measurements by 
trained nurses and repeatability of these measurements were likely to have 
increased the reliability of the data and results.   
The issue of external validity is the question to what extent one may 
generalize and apply the conclusion derived from this study to the general 
population of Bangladesh. Since the current study was a population based 
study where samples were from a representative general population provided 
a baseline data regarding the prevalence and risk factors of diabetes and 
retinopathy. Therefore this study would contribute to prevention approaches 
and suggestions to address these problems.  
5.2.3 The limitation of the study 
Some limitations should however be pointed out in the present study. The 
cross-sectional nature of this study was the major limitation. In the cross-
sectional method we have measured the disease outcome and exposure at the 
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same point in time. The cross-sectional nature limits the causal interference 
between disease outcome and exposure. Therefore, we cannot draw any firm 
conclusion regarding the risk factors since the data on temporal sequence is 
lacking. It is just a description of diseases or exposure at one time point. It is 
important to be aware that multiple factors may have influenced the 
dependent factors- diabetes or retinopathy. To control for the confounding 
factors, multivariate logistic regression analysis was done with diabetes or 
retinopathy as the dependent variables. However, it cannot exclude the 
possibility of some uncontrolled variables which were not included in the 
study and in the analysis. 
Nevertheless, we would have needed a much larger sample size in order to 
generalize our results in whole Bangladeshi population. As we had limited 
time frame and resources to conduct the study, we used the most convenient 
formula to calculate the sample size for estimating diabetes prevalence. 
Therefore, the sample size became smaller which may decrease the statistical 
power. The small sample size is a possible cause for only being able to 
identify the established risk factors like age and hypertension for developing 
diabetes, as statistically non significant but marginal risk factors. With a 
bigger sample size, it may be assumed that age and hypertension would have 
become statistically highly significant risk factors for developing diabetes in 
this population.  Furthermore, it can be argued that the sample size 
calculation was not properly done for estimating the prevalence of 
retinopathy in this population. So far, no study has been conducted either in 
Bangladesh or in the Asian subcontinent on the extent of retinopathy and its 
association with glucose metabolism including non diabetic general people as 
well; it was difficult to get any data, which we could have used to estimate 
our desired sample size. 
5.3 Implications 
In view of the fact that the present study was a population based one which 
provided a baseline data regarding the prevalence and risk factors of diabetes 
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and retinopathy. Therefore this study would contribute to appropriate 
prevention approaches and suggestions to address these problems. The result 
of the current study may lay the foundation to develop policies necessary to 
cope with the challenges of the disease burden. It would contribute to all 
phase of prevention strategies in this population. Primary prevention aims at 
modification of the risk factors such as sedentary lifestyle, obesity, and 
hypertension and so on, in high risk population to reduce the occurrence of 
IGT and IFG. Secondary prevention aims to prevent the development from 
pre diabetes to overt diabetes. Tertiary prevention involves standardized 
treatment and management of diseases, for example, control of blood glucose 
to prevent the complications of diabetes and improve the life quality.  
Some participants of the study were diagnosed as newly detected diabetic 
and retinopathy subjects and could also be treated in early stage. Subjects 
with positive results would attach more importance to the treatment and 
management of diseases, so would their family. And also a large number of 
people were found with or at risk of diabetes and retinopathy which require 
more attention than that given at present. Several associated risk factors for 
developing diabetes and retinopathy were identified in the present study 
which will serve as basis of prevention. In conjunction with data from other, 
active prevention campaign can be done in the whole population aiming at 
altering modifiable risk factors and with emphasis on population with 
nonmodifiable risk factors. It can also enhance people’s concern of prevention, 
control and decrease the possibility of disease occurrence. Moreover, 
associated factors identified in our study are expected to be similar with other 
Bangladeshi population in other parts of the country or Bangladeshi overseas 
immigrants. Therefore, similar intervention and prevention suggestions can 
be made for Bangladesh in general.      
As explained in the beginning, prevention is the most cost-effective method to 
deal with these problems. Extensive prevention and control of diseases in the 
society is, in fact, not a research issue any more, but it needs the cooperation 
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and effort of many stake holder including government, NGOs, media and 
general people. It is only the feasible approach to help reverse the negative 
trends in the incidence of diseases. 
5.4 Recommendation 
In addition to useful experiences and observations made during the field 
work, the data presented in this study generated several issues that warrant 
further evaluation. In a society like Bangladesh, where the resources are 
already diminutive relative to its population size, the increasing life 
expectancy and elevated prevalence of diabetes, retinopathy and diabetic 
retinopathy may dramatically raise the burden and expenses of the health 
care system. The important recommendation is related to the knowledge 
regarding diabetes and its associated microvascular complications and 
retinopathy. In order to prevent this disease burden the community needs to 
be mobilized. It is strongly suggested to involve the local community in 
awareness building activities to encourage people to seek health care facilities. 
It was noticeable that a significant number of participants never visited any 
ophthalmologist before the eye camp because of unawareness. Ultimately, the 
patient is responsible for his/her own health. So everybody needs to be aware 
of the risk factors. The attention regarding these issues should be increased to 
reduce the total burden of those diseases, suffering of the patients, their 
families and the community. Maintenance of optimal glycemic status, healthy 
weight, blood pressure, lipid level and proteinuria deserve closer 
consideration. Feasible diagnostic tests may be applied in health care services 
in a developing country like Bangladesh to identify patients at high risk of 
developing these complications. These risk factors should be identified in 
time and the person should receive improved health care immediately.  
Necessary follow-up activities may be designed to increase awareness, to 
diminish the risk and further, to reduce the burden and cost for both to the 
individual and the society at large.  
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In order to address this issue, large-scale cohort studies are required with 
control population. Furthermore, this work gives new information on the 
prevalence and associated risk indicators of retinopathy in one region of 
Bangladesh. While there were imperfection in the design and execution of the 
study, it does highlight several problems that must be addressed and 
overcome if definitive data are to be produced from subsequent studies. 
Further research should be executed regarding both issues.  
5.5 Conclusions  
Since literacy rate is comparatively lower in northern part of Bangladesh and  
most of the people are poor and hardly perceiving the need of early health 
care services, this kind of study, which was held in the peripheral areas of 
Thakurgaon district, is a strategic approach to identify diabetes and eye 
diseases. The higher prevalence of diabetes (7.2%), diabetic retinopathy 
(21.6%) and nondiabetic retinopathy (3.5%) found in the present study, 
indicated the changing environmental factors which may have increased 
occurrence of these diseases. Even though the sample size of this study is 
relatively small, the findings should be interpreted with caution. Adequate 
treatment of the risk indicators might prevent and reduce the burden of these 
diseases and improve the quality of health care services.  
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ABSTRACT 
Objective: The purposes of the study are to estimate the prevalence of 
diabetes and to identify its associated risk factors in a rural Bangladeshi 
population. 
Methods: This population based cross-sectional study was conducted 
through screening in camp settings, which included a total of 836 participants 
(aged ≥25 years) by following simple random procedure. Fasting blood 
glucose (FBG) and oral glucose tolerance test (OGTT) were performed for all 
participants to diagnosis diabetes according to the diagnostic criteria of World 
Health Organization. Anthropometric measurements (BMI and WHR), blood 
pressure, lipid profile and urine albumin creatinine ratio were also estimated.  
Results: An increased prevalence of diabetes was found with 7.2% (95% CI 
5.4-9.0) in the present study. A superior agreement was observed between 
FBG and OGTT (Kappa value 0.86) among the study participants. Non 
significant female predominance was observed compared with male for 
developing diabetes in rural Bangladesh. After adjusting for potential 
confounders BMI, WHR, serum creatinine, triglyceride, total cholesterol and 
UACR were found as significant independent risk indicators for the 
occurrence of diabetes in this population.  
Conclusion: The indices of obesity (increased BMI and WHR), 
hyperlipidemia (increased triglyceride and cholesterol) and urine ACR may at 
least in part explain the rising trend of diabetes mellitus in this rural 
population of Bangladesh. Considering rapid urbanization influencing 
individual’s lifestyle leading to increase occurrence of diabetes, prospective 
studies are required in order to address this issue. 
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INTRODUCTION 
Diabetes mellitus (DM) is becoming a pandemic worldwide. According to the 
World Health Organization (WHO) Report there were 171 million people 
worldwide with diabetes in 2000 and predicted that the prevalence of this 
disease will increase to 366 million by 2030 (1). The highest percentages of 
increases in disease prevalence are likely to be in developing nations. It is 
estimated that the developing countries will bear the brunt of this epidemic in 
the 21st century, with 80% of all new cases of diabetes expected to appear in 
the developing countries by 2025 (2), with major increases in the Middle-East, 
Sub-Saharan Africa, South Asia, and Latin America (1).  
WHO listed 10 countries to have the highest numbers of people with diabetes 
in 2000 and 2030 (1). Bangladesh appears in the list for both 2000 and 2030 
with India, Pakistan, China, Japan and USA etc. According to the report, 
Bangladesh has 3.2 million of diabetic subjects, and the number is expected to 
increase to a staggering 11.1 million by 2030. Several small-scale population 
based studies conducted in Bangladesh at different time points have revealed 
an increasing trend of diabetes prevalence in rural and urban communities (3-
10). A recent population based study (4) showed a significant increase in the 
prevalence of DM in rural Bangladesh from 2.3% to 6.8% over 5 years. This 
prevalence was higher than found in the previous rural studies of Bangladesh 
(6, 8). 
Abdominal obesity as measured by waist/hip ratio (WHR), general obesity as 
measured by body mass index (BMI), hypertension and dislipidemia are 
common indicator for diabetes mellitus. There are several epidemiologic and 
physiologic evidence linking insulin resistance and hyperglycemia to the 
presence of these predictors (11-15). The pattern of diabetes in Bangladeshi 
population differs from that in Europeans and Americans in several aspects: 
The onset is at a younger age, obesity is less common, and changes in lifestyle 
appear to be stronger. However, the association of obesity and diabetes in this 
population is unconventional. Some studies showed that BMI and WHR were 
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important predictors of diabetes in rural Bangladeshi population, although 
the population was considered as lean (4, 6), while the others did not (3, 5). 
Combination of low BMI and relatively high central obesity with increasing 
prevalence of DM are general features of diabetes in Bangladeshi population. 
These clinical differences and the rising prevalence of diabetes in Bangladesh 
warrant well-conducted epidemiologic studies on diabetes including lipid 
profile, serum creatinine and urine albumin creatinine ratio (UACR) as 
possible confounders for DM in this population. The study was conducted to 
observe the sequential changes in the prevalence of diabetes and to identify 
its associated risk factors in a rural Bangladeshi population. 
MATERIALS AND METHODS 
Study area and population 
Bangladesh has 64 districts and the study was conducted in one district of 
northern Bangladesh called Thakurgaon. Thakurgaon is in the north-west 
corner of Bangladesh, it is about 467 km from Dhaka, the capital of 
Bangladesh. The district is a part of the Himalayan plain land and the state of 
India lies on its west and north side. This district has 5 upazilas (sub-district). 
Subjects were recruited from all upazilas by following simple random 
procedure.  
This study was only a part of an ongoing large epidemiologic study of 
Bangladesh Diabetic Somity, involving a representative population of 
Thakurgaon district. To determine the required sample size for this part of 
study, the formula: n = PQ/d2 was used. Where P for prevalence (of DM + Pre 
DM) from the previous study, i.e. 0.14 (14%); Q = 1 – P, i.e. 0.86 and d = 
allowable error of known prevalence i.e. 0.085 × 0.14. Thus the sample size, n 
= 850. Following a simple random procedure 1000 individuals aged ≥25 years 
were identified to participate in this study. Among them 836 individuals 
agreed to participate and were investigated in the present study.  
Ethical consideration 
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The protocol was approved by the Norwegian Ethical Committee for Medical 
Research and the National Ethical Committee of Bangladesh. Administrative 
clearance was obtained from Bangladesh Ministry of Public Health, the 
District Medical Officer and local official institutes. All participants signed an 
informed consent form prior to commencing any study procedure. However, 
the participants who were illiterate gave verbal consent and the witness 
signed on the document on behalf of the participant. They were informed of 
their rights to withdraw from the study at any stage of the study without 
giving any notification of reasons. The written results of medical examination 
were distributed and explained to the participants through Thakurgaon 
Swasthoseba Hospital, the Health Care Center of the Bangladesh Diabetic 
Somity. The identified cases for diabetes were referred to this hospital for 
follow up and further treatment.   
Survey procedures 
The study was a population based cross-sectional study. This epidemiological 
survey was conducted through screening in camp settings. Three camps were 
organized in 3 different places by Thakurgaon Swasthoseba Hospital within 6 
months. The first camp was held on June 2008, second camp on August 2008 
and the last camp on December 2008. Each camp continued for two days.  
Sixteen field assistants were recruited from the local community and trained 
for the field work which included sample selections, organizing the screening 
camps, collection of data by reviewing the questionnaire and delivering the 
results to the participants. Seven days of training were provided to the 
assistants for selection process, interview and data collection prior to the 
commencement of the study. Each trainee was evaluated before he or she was 
allowed to participate in the study. The field assistants listed all the adults 
aged ≥25 years from each area and identified the required number of subjects 
following simple random procedure. Pregnant women and physically or 
mentally disabled persons unable to follow simple questions were excluded 
from the study.  
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All the individuals selected for the study were given an identification 
number. The field assistants approached the potential participants by an 
information letter and a respond document. Participants were informed of the 
purpose and the procedure of the study and they were requested to attend the 
screening camps in the morning on a pre-arranged date after an overnight fast 
of at least 8-10 hours. Each and every subject was made aware and was 
explained the necessity of the fasting state of a minimum 8-10 hr prior to the 
test. On arrival at the pre scheduled time (7.30 am to 8.30 am) on the 
appointed day, confirmation of the fasting state was taken/verified once 
again from each participant.  After receiving the consent general registration 
of the participant was initiated. With proper aseptic precaution, initial 8 ml of 
venous blood and urine sample were collected from each participant. Fasting 
blood glucose (FBG), lipid profile, serum creatinine and glycosylated 
hemoglobin (HbA1c) were determined from fasting blood sample and 
albumin creatinine ratio (ACR) was measured from urine sample. All subjects 
other than those with known diabetes (n=22) were then given a 75-g oral 
glucose solution (75-g oral glucose load dissolved in 500 ml of water) to drink. 
Another 3 ml of venous blood was collected after 2 hours to determine 2 hr 
post oral glucose tolerance test (OGTT). 
During the 2 hr waiting period the participants were interviewed for some 
general information through the preseted questionnaire and were measured 
some biophysical parameters which include anthropometric measures 
(height, weight, waist circumference and hip circumference). Further blood 
pressure measurement was recorded.  
After collecting the blood and urine sample it was centrifuged on the site 
within 3 hours to separate plasma. All samples were then refrigerated and 
stored at -200C until laboratory assays was done. Fasting blood glucose (FBG) 
and oral glucose tolerance test (OGTT) were analyzed by glucose oxidase 
method (Randox, UK) for the diagnosis of diabetes mellitus. Lipid profile 
includes total cholesterol (TC), high-density lipoprotein (HDL), low-density 
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lipoprotein (LDL) and triglycerides (TG), which were measured by enzymatic 
technique. Glycosylated hemoglobin (HbA1c) was measured by high-
performance liquid chromatography (HPLC). 
Interviewer administered questionnaire:  
The preseted questionnaire was composed of some general information; like 
the demographic and socioeconomic information, including name, sex, age, 
education, occupation and economic status. The participants were asked for 
their 1st degree family history of diabetes and associated complications of 
diabetes, if any, (nephropathy, neuropathy, hypertension, hyperlipidaemia, 
coronary artery diseases). They were also asked for some information related 
to their own medical history of obesity, hypertension, diabetes and associated 
complications of diabetes. 
Anthropometrical measurement 
Anthropometric measurements included height, weight, waist circumference 
and hip circumference. The measurements were taken with light clothes 
without shoes. Height was measured by using a portable, locally 
manufactured, stadiometer, standing upright on a flat surface without shoes 
to the nearest 0.1 cm. Body weight was measured while wearing light clothes 
by an adjusted scale and recorded to the nearest 0.1 kg. Body mass index 
(BMI) was calculated by the formula: weight in kilograms divided by height 
in meters squared [weight (kg)/height (m2)]. Waist circumference was 
measured at 1 cm above the level of navel at minimal respiration and hip 
circumference was measured at the level of maximum posterior extension of 
the buttocks by placing a flexible plastic tape horizontally with light clothes. 
Both circumferences were recorded to the nearest 0.1 cm. Two readings of 
height, weight, waist circumference and hip circumference were recorded and 
the mean of the two was taken as the final reading. Asian BMI criteria were 
used to identify overweight and obese in this population (16). Five categories 
of BMI were identified here for presenting the data. Individuals with BMI 
below 18.49 kg/m2 classified as  underweight, healthy weight (BMI  18.5-
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22.99  kg/m2), overweight (BMI  23.0-24.99  kg/m2), obese I (BMI 25.0-29.99 
kg/m2)  and obese II (BMI over 30.0  kg/m2)), respectively. Abdominal 
obesity was evaluated by waist/hip ratio, with android and gynaecoid cut off 
points taken at 0.8 and 0.9 for females and males respectively (17). 
Blood pressure measurement 
Blood pressure was taken after completion of the questionnaire. To reduce the 
variation, subjects rested for at least 10 minutes before the BP was recorded. 
The pressure was measured in sitting position on the right arm using normal 
cuffs for adults fitted with a standard mercury sphygmomanometer, placing 
the stethoscope bell lightly over the brachial artery. BP was usually recorded 
to the nearest 2 mm Hg from the top of the mercury meniscus. Two readings 
were taken 5 minutes apart, and the mean of the two was taken as the final 
blood pressure reading of the individual. Hypertension was defined as a 
systolic blood pressure (SBP) of ≥ 140 mm Hg and/or diastolic blood pressure 
(DBP) of ≥ 90 mm Hg (18). 
Diagnosis criteria for diabetes 
After estimation of fasting blood glucose (FBG) and oral glucose tolerance test 
(OGTT), the participants were classified into non diabetes, diabetes mellitus, 
IFG (impaired fasting glucose) and IGT (impaired glucose tolerance), 
according to the recommendation of the World Health Organization Expert 
Committee (18). Subjects were defined as having diabetes mellitus (n = 60) 
based on their fasting blood glucose levels ≥ 7.0 mmol/l or 2 hr post glucose 
levels ≥11.1 mmol/l or both. IFG was defined when FBG values were between 
6.1-7.0 mmol/l and OGTT <7.8 mmol/l. IGT was defined when FBG <7.0 
mmol/l and OGTT values were between 7.8-11.1 mmol/l. IFG and IGT 
subjects were together called pre diabetes (n = 54).  
Criteria for other variables 
According to the ADA recommendation (35) the cut of value of other 
variables like, total cholesterol (<200 mg/dl), triglyceride (<150 mg/dl), LDL 
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(<100 mg/dl), HDL (for male >50 mg/dl and for female >40 mg/dl), serum 
creatinine (for male <1.4 mg/dl and for female <1.2 mg/dl) and urine 
albumin creatinine ratio (<30 mg/g) was used for data analysis. 
Data analysis 
The data was entered in the pre-designed Microsoft office excel format which 
was imported later into the statistical software SPSS. The prevalence rates of 
diabetes were determined by simple percentages. Statistical comparisons 
between categorical variables were made by using χ2 test and comparisons 
between continuous variables were made by using independent sample t test. 
The odds ratio (OR) with 95% confidence interval (CI) for risk factors was 
calculated assuming the least prevalence of clinically relevant criteria as a 
reference value. Multiple logistic regression were performed to quantify the 
individual effect of predictor variables and to adjust for potential 
confounding factors. All P-values presented are two-tailed.  The statistical 
tests were considered significant at a level ≤5% (≤0.05). All the statistical 
analysis were performed using SPSS 16 software. 
RESULTS  
Table P1.1: Prevalence rate of diabetes and pre diabetes (IGT & IFG) by age 
and gender distribution 
Diabetic cases Prevalence per 
100 
Age group 
in years 
Male Female 
Male Female Male Female 
Total 
prevalence 
P for 
difference 
25-40 yrs 162 164 10 8 6.2 4.9 5.5 0.609 
41-55 yrs 172 128 12 9 6.9 7.0 6.9 0.985 
above 55 
yrs 
134 76 10 11 7.5 14.5 11.0 0.068 
Total 468 368 32 28 6.8 7.6 7.2 0.668 
 
Pre diabetic cases Prevalence per 100 Age group 
in years 
Male Female 
Male Female Male Female 
Total 
prevalence 
P for 
difference 
25-40 yrs 162 164 6 12 3.7 7.3 5.5 0.104 
41-55 yrs 172 128 10 10 5.8 7.8 6.8 0.492 
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above 55 yrs 134 76 10 6 7.5 7.9 7.7 0.811 
Total 468 368 26 28 5.5 7.6 6.5 0.231 
The overall prevalence of diabetes was 7.2% (95% CI 5.4-9.0) and pre diabetes 
(both IGT & IFG) was 6.5% (95% CI 4.8-8.2). Prevalence of diabetes and pre 
diabetes increased with increasing age both for males and females (Table 1). 
Though non-significant, females had higher prevalence of both diabetes and 
pre diabetes compared with males in all age group. The difference in 
prevalence of diabetes by sex widened in the older age group (>55 years). But 
for pre diabetes, the difference in prevalence by sex was wider in the younger 
age group (25-40 years), while the difference was very narrow in the older age 
group (>55 years). 
Table P1.2:  Distribution of participants for different variables by age and 
gender 
25-40 yrs 41-55 yrs above 55 yrs  
Variables Male 
(n=162) 
Female 
(n=164) 
P for 
differ
ence 
Male 
(n=172) 
Female 
(n=128) 
P for 
differ
ence 
Male 
(n=134) 
Female 
(n=76) 
P for 
differ
ence 
BMI (kg/m2) 21.4±3.2 21.6±3.5 0.650 22.3±3.6 21.8±3.7 0.141 22.9±4.2 22.5±4.6 0.585 
WHR* 0.89±0.06 0.87±0.07 0.018 0.92±0.07 0.88±0.07 0.001 0.93±0.07 0.92±0.08 0.122 
SBP (mmHg) 117.7±15.4 113.4±15.8 0.014 119.7±16.8 121.3±22.6 0.490 123.7±19.1 125.1±20.1 0.418 
DBP (mmHg) 77.5±10.8 74.6±11.6 0.029 78.2±11.4 80.3±15.5 0.253 78.7±12.9 81.2±15.0 0.196 
FBG (mmol/l) 5.03±1.7 5.05±1.8 0.913 5.1±1.5 5.3±2.1 0.277 5.2±1.4 5.7±2.3 0.142 
AG (mmol/l) 5.9±2.3 6.2±2.6 0.209 6.1±2.7 6.4±3.1 0.325 6.4±3.0 7.3±4.5 0.146 
HbA1c (%) 4.9±1.2 5.01±1.1 0.480 5.1±1.3 5.1±1.2 0.996 5.4±1.4 5.8±1.9 0.172 
S Creatinine 
(mg/dl)* 
1.12±0.23 1.03±0.21 0.001 1.24±0.33 1.16±0.26 0.050 1.40±0.40 1.31±0.43 0.062 
Triglyceride 
(mg/dl) 
156.4±65.3 135.9±54.7 0.002 156.6±62.1 155.7±56.9 0.936 162.2±65.3 163.4±71.9 0.912 
Cholesterol 
(mg/dl) 
187.3±32.4 178.0±32.9 0.013 189.5±40.6 192.9±35.2 0.642 190.8±40.3 198.3±40.5 0.068 
HDL (mg/dl)* 36.8±8.4 34.1±8.3 0.010 37.8±11.1 34.8±7.4 0.002 38.0±11.2 37.3±8.6 0.615 
LDL (mg/dl) 119.7±29.6 116.5±30 0.332 127.1±37.6 126.2±33.6 0.702 118.2±37.1 124.1±39.4 0.310 
UACR (mg/g) 13.7±6.2 13.9±5.8 0.996 13.9±6.7 14.7±6.9 0.470 18.3±7.9 18.7±8.4 0.824 
Data are presented as mean±SD; independent t- test was done as a test of significance.  
Abbreviations: BMI, Body mass index; WHR, Waist hip ratio; SBP, Systolic blood pressure; DBP, 
Diastolic blood pressure; FBG, Fasting blood glucose; AG, After 2 hr glucose load; HbA1c, 
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Glycosylated hemoglobin; HDL, High density lipoprotein; LDL, Low density lipoprotein; UACR, 
Urine albumin creatinine ratio 
* Data were coded with reference value separately for male and female and then analyzed together.  
General characteristics of the participants were presented by gender in table 2 
with 15 years age interval. Among the 836 participants 56% (n=468) were 
male and 44% (n=368) were female participants. The mean age of the 
participants was 46 years. Male subjects were older compared to the female 
participants. There were no differences in BMI between male and female 
participants in all age strata. However the mean BMI was 22.2 and 21.9 for the 
male and female participants, respectively. Mean BMI was increased 
according to the age group for both males and females. This picture is also 
reflected in the assessment of other parameters except for LDL. In younger 
age group there were significant differences in systolic blood pressure, 
diastolic blood pressure, triglyceride and total cholesterol between male and 
female participants. But it is not reflected in other age groups. A superior 
agreement was observed between FBG and OGTT (Kappa value 0.86) among 
the study participants (data has not shown).  
Table P1.3: Baseline characteristics of diabetic, pre diabetic and non diabetic 
people 
Variables Diabetic 
(n=60) 
Non 
Diabetic 
(n=722) 
P for 
differ
ence 
Pre 
Diabetic 
(n=54) 
Non 
Diabetic 
(n=722) 
P for 
differ
ence 
Diabetic 
(n=60) 
Pre 
Diabetic 
(n=54) 
P for 
differ
ence 
Age (yrs)  48.8±10.7 45.3±11.8 0.019 47.0±11.4 45.3±11.8 0.285 48.8±10.7 47.0±11.4 0.408 
BMI (kg/m2) 23.9±4.7 21.7±3.6 0.002 23.1±4.4 21.7±3.6 0.006 23.9±4.7 23.1±4.4 0.235 
WHR * 0.97±0.09 0.89±0.07 0.001 0.92±0.06 0.89±0.07 0.005 0.97±0.09 0.92±0.06 0.004 
SBP (mmHg) 129.4±18.7 118.0±17.9 0.001 126.4±19.2 118.0±17.9 0.003 129.4±18.7 126.4±19.2 0.402 
DBP (mmHg) 85.8±15.6 77.2±12.4 0.001 81.5±12.5 77.2±12.4 0.018 85.8±15.6 81.5±12.5 0.066 
FBG (mmol/l) 10.5±3.1 4.7±0.60 0.001 6.3±0.40 4.7±0.60 0.001 10.5±3.1 6.3±0.40 0.001 
AG (mmol/l) 14.9±4.1 5.3±1.0 0.001 9.2±1.5 5.3±1.01 0.001 14.9±4.1 9.2±1.5 0.001 
HbA1c (%) 8.6±1.9 4.8±0.68 0.001 6.8±0.91 4.8±0.68 0.001 8.6±1.9 6.8±0.91 0.001 
S Creatinine 
(mg/dl)* 
1.66±0.60 1.16±0.28 0.001 1.27±0.30 1.16±0.28 0.019 1.66±0.60 1.27±0.30 0.001 
Triglyceride 
(mg/dl) 
250.1±75.5 143.5±53.1 0.001 186.5±70.7 143.5±53.1 0.001 250.1±75.5 186.5±70.7 0.001 
Cholesterol 
(mg/dl) 
220.2±46.4 184.7±35.0 0.001 209.1±40.4 184.7±35.0 0.001 220.2±46.4 209.1±40.4 0.221 
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HDL (mg/dl)* 33.9±9.3 37.2±10.1 0.024 33.2±6.9 37.2±10.1 0.001 33.9±9.3 33.2±6.9 0.480 
LDL (mg/dl) 136.2±46.1 119.5±32.8 0.008 138.1±38.3 119.5±32.8 0.001 136.2±46.1 138.1±38.3 0.804 
UACR (mg/g) 18.4±8.2 14.1±7.2 0.001 16.8±7.8 14.1±7.2 0.016 18.4±8.2 16.8±7.8 0.135 
Data are presented as mean±SD; independent t- test was done as a test of significance.  
Abbreviations: BMI, Body mass index; WHR, Waist hip ratio; SBP, Systolic blood pressure; DBP, 
Diastolic blood pressure; FBG, Fasting blood glucose; AG, After 2 hr glucose load; HbA1c, 
Glycosylated hemoglobin; HDL, High density lipoprotein; LDL, Low density lipoprotein; UACR, 
Urine albumin creatinine ratio 
* Data were coded with reference value separately for male and female and then analyzed together.  
The characteristics were compared between subjects with diabetes (n=60) & 
non diabetes (n=722), pre diabetes (n=54) & non diabetes (n=722) and diabetes 
(n=60) & pre diabetes (n=54) (Table 3). The subjects with diabetes were 
significantly older with higher BMI, WHR, blood pressure, serum glucose 
(fasting and 2 hr after glucose), HbA1c, serum creatinine, triglyceride, total 
cholesterol, LDL, UACR and significantly lower HDL compared to subjects 
with non diabetes. Although non significant, the subjects with pre diabetes 
were older than non diabetes subjects. The comparison of other characteristics 
between pre diabetes and non diabetes subjects yielded similar results. The 
subjects with diabetes had significantly higher WHR, serum glucose (fasting 
and 2 hr after glucose), HbA1c, serum creatinine and triglyceride compared to 
subjects with pre diabetes. Although non significant, diabetes subjects had 
higher age, BMI, blood pressure, total cholesterol, HDL, UACR and lower 
LDL compared to subjects with pre diabetes. 
Table P1.4: Prevalence, odds ratio (OR) and 95% CI of diabetes by the 
following risk factors  
  
Variables Diabetic 
cases 
n Prevalence 
per 100 
OR 1 (95% CI) OR 2 (95% CI) 
Age (yrs)      
25-40 * 18 326 5.52 1.0 1.0 
41-55  21 300 7.00 1.90 (1.18-3.66) 0.78 (0.34-1.74) 
Above 55  21 210 10.00 1.48 (0.98-2.78) 0.92 (0.46-2.03) 
Sex      
Male * 32 468 6.84 1.0 1.0 
Female 28 368 7.60 1.12 (0.66-1.90) 1.13 (0.60-2.14) 
BMI (kg/m2)      
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18.5-22.99 normal * 17 377 4.51 1.0 1.0 
Below 18.49 underweight  15 173 8.67 0.94 (0.62-6.32) 0.85 (0.56-3.50) 
23.0-24.99 overweight 8 60 13.3 2.92 (1.62-7.04) 2.50 (1.49-6.32) 
25.0-29.99 obese I 10 180 5.55 4.72 (1.83-12.17) 3.94 (1.39-11.21) 
Above 30.0 obese II 10 46 21.74 5.88 (2.51-13.8) 4.65 (2.12-12.65) 
WHR       
Normal * 8 226 3.54 1.0 1.0 
High 52 610 8.52 2.54 (1.59-5.43) 1.81 (1.16-4.34) 
SBP (mmHg)      
Below 140 * 36 663 5.43 1.0 1.0 
Above 140 high 24 173 13.87 2.81 (1.62-4.85) 1.38 (0.89-3.92) 
DBP (mmHg)      
Below 90 * 35 657 5.33 1.0 1.0 
Above 90 high 25 179 13.96 2.89 (1.68-4.96) 1.62 (0.98-4.52) 
S Creatinine (mg/dl)      
Normal * 33 671 4.92 1.0 1.0 
High 27 165 16.36 3.78 (2.20-6.50) 3.40 (1.77-6.55) 
Triglyceride (mg/dl)      
Below 150 * 17 475 3.58 1.0 1.0 
Above 150 43 361 11.91 3.64 (2.04-6.50) 2.37 (1.55-5.37) 
Cholesterol (mg/dl)      
Below 200 * 25 584 4.28 1.0 1.0 
Above 200 35 252 13.88 3.61 (2.11-6.17) 2.03 (1.15-3.92) 
HDL (mg/dl)      
Normal * 11 217 5.07 1.0 1.0 
Low 49 619 7.91 1.61 (0.82-3.16) 1.24 (0.55-2.71) 
LDL (mg/dl)      
Below 100 * 14 251 5.58 1.0 1.0 
Above 100 46 585 7.86 1.45  (0.78-2.68) 0.79 (.34-1.64) 
UACR (mg/g)      
Below 30 * 47 312 15.06 1.0 1.0 
Above 30 13 45 28.88 2.29 (1.42-4.68) 1.89 (1.14-3.26) 
Abbreviations: OR, Odds ratio; CI, Confidence interval; BMI, Body mass index; WHR, Waist hip 
ratio; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; HbA1c, Glycosylated hemoglobin; 
LDL, Low density lipoprotein; UACR, Urine albumin creatinine ratio 
OR 1, Crude odds ratio after univariate logistic regression; OR 2, Adjusted odds ratio for age, sex, 
glucose metabolism category, BMI, WHR, SBP, DBP, hypertension, HbA1c, S Creatinine, Lipids and 
UACR  
* Referent  
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We used logistic regression to quantify the individual effects of age, sex, BMI, 
WHR, SBP, DBP, S Creatinine, Lipids and UACR with diabetes (Table 4). Age, 
BMI, WHR, SBP, DBP, S Creatinine, triglyceride, total cholesterol and UACR 
were found to be significant risk factors for the occurrence of diabetes 
mellitus in the univariate model. After adjusting for potential confounders in 
the multivariate model by using all variables BMI, WHR, S Creatinine, 
triglyceride, total cholesterol and UACR remained as significant independent 
risk indicators for the occurrence of diabetes in this population. BMI >23.0 
showed to be exceedingly risky state for the occurrence of diabetes. The risk 
for diabetes was almost 2-fold or sometimes more than 2-fold higher in 
subjects with BMI >23.0 kg/m2, high WHR both for male and female, high 
serum creatinine for both sex, triglyceride >150 mg/dl, cholesterol >200 
mg/dl and UACR >30 mg/g. 
DISCUSSION 
This study addressed the prevalence of diabetes and pre diabetes in a rural 
population in Bangladesh. The prevalence of diabetes was found to be 7.2% 
which is comparable to the recent rural studies (6, 7, 9), but significantly 
higher than the studies conducted in early 2000s (3, 4, 5). However, moderate 
but steady rise in the prevalence of pre diabetes (6.5%) was observed 
compared to a recent published data (3), but rather a lower prevalence 
compared to another study (6). Data on the rising trend of diabetes in 
Bangladesh were based on the comparison of data collected from different 
parts of the country at different times and had applied different procedures, 
other than one (4). Therefore, it is difficult to make a scientific comprehension 
of the rising trend of diabetes. To compare secular trends, it would be more 
accurate to document the prevalence of diabetes within the same region 
applying the identical procedure. 
The prevalence of diabetes documented in this study was comparatively 
higher than the prevalence found in rural China (5.6%), but more related to 
that of rural India (6.3%) and was equal to that of rural population in Turkey 
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(7.2%) (19, 20, 21). However, the observed prevalence rate of diabetes in this 
report is lower than the prevalence found in rural Pakistan (11.1%) (22). But 
the direct comparisons of prevalence rates are challenging owing to 
differential methodologies applied and diverse characteristics of the 
population.  
Several studies showed that urbanization, economic development and 
affluent lifestyle are causing high prevalence of DM even in the developing 
countries (23, 24, 25). The rural Bangladeshi population is undergoing lifestyle 
transition due to socio-economic growth; road communication, electrification, 
and mechanized cultivation in recent years and have changed the rural 
lifestyle. This demographic transition due to improved living conditions in 
rural area was associated with this increased rate in the prevalence of diabetes 
in rural Bangladesh. But BMI in this population remain low. Therefore, it 
would be difficult to ascribe the increased prevalence only due to higher 
calorie intake as a consequence of improved socio-economic condition. Rather 
higher pre diabetes in a lean population may also indicate genetically 
susceptible population, who may convert to diabetes with a much lower 
change in obesity, although the BMI may remain low. Thus there could be a 
rapid progression from the normal state through pre diabetes to diabetes, 
which could imply a rapid increase in the diabetes epidemic or a worsening 
diabetogenic environment. Prospective studies are required to assess the exact 
changes occurring with regard to the diabetes epidemic in Bangladesh. 
We have observed a higher, though non significant, occurrence of diabetes 
and pre diabetes among females in almost all age categories compared with 
males especially in the highest age strata. The finding of female predominance 
is consistent with the most previous studies in Bangladesh (4, 5, 7, 8). We have 
observed higher mean values of FBG and AG among females in all age group 
compared to males. Gender difference was not significant in India (26), 
though non significant higher prevalence of type 2 diabetes was found among 
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women in another investigation in India (27). Higher prevalence of diabetes in 
women was found in Pakistan (22) and Turkey (21). 
As obesity is an established risk factor for diabetes, we have observed an 
important association of both general obesity and central obesity with 
diabetes. It is of interest to note that general obesity was found to have more 
than 2-fold higher risk for developing diabetes in subjects with BMI >23.0 
kg/m2 in the present study. We had previously noted that the risk of diabetes 
occurred at a lower BMI threshold (<23 kg/m2) in Asian Indians (28). Data 
from recent studies in Bangladesh did not show any significant association 
between BMI and diabetes (3, 5). However, in other studies higher BMI (>25.0 
kg/m2) was found as an important predictor for occurrence of type 2 diabetes 
(4, 7, 9). But the population from previous studies showed lean BMI. A study 
in India (29) found the prevalence of diabetes was high even though the rates 
of obesity were low among the Indian urban and rural population. WHR also 
appeared to be a significant risk factor for diabetes in the multivariate 
analysis. The association between WHR and DM was evident in the earlier 
studies in Bangladesh (7, 30). We have also noticed that the risk of diabetes 
occurred by central adiposity along with lower BMI threshold in Asian 
Indians (28). We have observed central obesity even among people with 
normal BMI in our population (data has not shown). Therefore, the transition 
in lifestyle occurring in the rural population seemed to produce rapid adverse 
changes favoring diabetogenesis. 
Another interesting observation in this present study was that the lipids 
(triglyceride and total cholesterol) showed as strong risk factor for developing 
diabetes in rural population of Bangladesh. But this significant association 
was conflicting with earlier rural study (6). Surprising fact of this study was 
that systolic and diastolic hypertension was significantly associated with the 
occurrence of diabetes mellitus in the univariate model but non significant 
marginal risky state was observed in the multivariate logistic regression. Only 
one earlier study among rural subjects showed a significant association with 
 72
both systolic and diastolic hypertension and higher glycemic status (31). 
Other recent studies observed significant association only between systolic 
hypertension and diabetes (4, 5). The inconsistent association between 
diabetes and hypertension has been previously reported in many ethnic 
groups and the role of hyperglycemia in determining blood pressure for 
ethnic differences are evident from these studies (32-34).  
Very few data are available on the extent of urine albumin-creatinine ratio 
(UACR) as a strong predictor for the occurrence of diabetes mellitus. But there 
has been considerable focus on the concept that, it is an important marker for 
more pronounced diabetic vascular complications like retinopathy as well as 
nephropathy. In the present study we tried to observe the association between 
UACR and diabetes as we don’t have any data regarding this. Here UACR 
was found as a significant risk factor for developing DM in this rural 
population of Bangladesh.  
Population based study design was the main strength of the study. It was the 
most appropriate and useful approach where samples from a representative 
population were tested. Therefore this study would contribute to prevention 
approaches and suggestions to address these problems. But we would have 
needed a much larger sample size in order to generalize our results in 
Bangladeshi population. As we had limited time frame and resources to 
conduct the study, we used the most convenient formula for calculate the 
sample size. Therefore, the sample size became smaller which may decrease 
the statistical power. Moreover, clinical sensitivity and specificity for the 
selection of different methods for different variables were considered here, 
which have increased the reliability of the data and results.  
The indices of obesity (increased BMI and WHR), hyperlipidemia (increased 
triglyceride and cholesterol) and urine ACR may at least in part explain the 
rising trend of diabetes mellitus in this rural population of Bangladesh. The 
higher prevalence of diabetes in the present study may also be indicated the 
changing environmental factors where rapid urbanization may have 
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influenced individual’s lifestyle leading to increased occurrence of diabetes. 
In order to address this issue, large-scale cohort studies are required with 
control population.  
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ABSTRACT 
Objective: This study aimed to make a baseline data focused on retinopathy 
regarding the prevalence in people with normal and abnormal glucose 
metabolism in rural Bangladesh and to identify the associated risk factors for 
developing retinopathy in this population. 
Methods: This population based cross-sectional study was conducted 
through screening in camp settings, which included a total of 836 participants 
(aged ≥25 years) by following simple random procedure. Retinopathy was 
determined by ophthalmoscopy and fundus photography. Anthropometric 
measurements (BMI and WHR), serum glucose (fasting and 2 hr after 
glucose), glycosylated hemoglobin, blood pressure, lipid profile and urine 
albumin creatinine ratio were also observed. Logistic regression analysis was 
used, without and with adjustment for potential confounders. 
Results: The overall prevalence rate of retinopathy was 5.4% (95% CI 3.9-6.9). 
Moreover, the prevalence of retinopathy among the diabetic, pre diabetic and 
non diabetic subjects were 21.6% (95% CI 11.2-32.0), 13% (95% CI 3.4-22.6) and 
3.5% (95% CI 2.2-4.8), respectively. Adjusted odds ratios for retinopathy were 
2.53 (95% CI, 1.52-5.41) for diabetic glucose metabolism and 1.98 (95% CI, 
1.17-5.63), 1.74 (95% CI, 1.09-3.02) and 1.63 (95% CI, 1.08-3.12) for 
hypertension, 2nd highest tertiles of glycosylated hemoglobin level and urine 
albumin creatinine ratio, respectively. Additionally, age, BMI, SBP, DBP, 
serum creatinine and total cholesterol were also found as significant 
independent risk indicators for the occurrence of retinopathy in this 
population. 
Conclusion: Finally, the study results suggest that, in addition to serum 
glucose control in diabetic patients, screening for hypertension, general 
obesity, hypercholesterolemia and proteinuria and adequate treatment of 
these risk factors might prevent retinopathy in rural Bangladeshi population. 
 79
INTRODUCTION 
Retinopathy, the potential sight threatening condition, is a significant public 
health problem; however this morbidity is largely preventable and treatable. 
It is significantly associated with impairment of vision and blindness (1). 
Retinal disease is frequent cause of blindness in developing countries (2). The 
socioeconomic burden resulting from visual impairment or blindness caused 
by retinopathy, particularly in working age group, is a serious concern. 
According to the World Health Organization worldwide there are an 
estimated 45 million people that are blind with an additional 135 million 
individuals visually impaired (3). Retinopathy is responsible for about 5% of 
those 45 million cases of blindness throughout the world. Worldwide, the 
prevalence of retinopathy is increasing at an alarming rate, possibly due to 
undetected cases of diabetes and as it has had a low priority in the prevention 
of blindness programs in developing countries.  
About 20 million Asians were estimated as blind by the World Health 
Organization (WHO), (4) and this figure is expected to increase as the 
population ages. The excellent and very detailed Andhra Pradesh Eye Disease 
Study (APEDS) found that retinal diseases were a much more common cause 
of adult blindness in India than had previously been thought (5). Enormous 
population based data of retinopathy in patients with diabetes mellitus, 
commonly termed as diabetic retinopathy (DR), has been published. But very 
few facts are available about other ocular and systemic causes of retinopathy 
or the clinical significance of retinopathy in patients without diabetes. There 
are few population based studies on the prevalence of diabetic retinopathy 
(DR) in Asia, with most originating from India (6-9). 
Apart from diabetes, other conditions associated with retinal ischemia, may 
lead to retinopathy (10). Retinopathy lesions are commonly seen in middle 
aged and elderly people with and without diabetes. Signs of retinopathy are 
structural markers of microvascular damage which has been strongly linked 
with hyperglycemia (11), elevated glycosylated hemoglobin level (12-14), 
 80
hypertension (15-17), lower glomerular filtration rates and microalbuminuria 
(18). One study found that retinopathy was associated with increasing fasting 
blood sugar concentrations in people not classified as having diabetes 
mellitus (19), although another study did not find this association (16). 
Nevertheless, the distinction between diabetes and prediabetes is somewhat 
arbitrary, and the results of some recent studies have shown that some of the 
subjects with IGT have had retinopathy (20, 21).    
There was only one nationally representative survey concerning the extent of 
blindness or the main causes of vision impairment in Bangladeshi adults, 
which has identified low level of diabetic retinopathy as the cause of visual 
impairment and moreover, no subject was found to be blind due to diabetic 
retinopathy (22). As the consequences of increasing trend of diabetes mellitus, 
the number of people with diabetic complications like retinopathy will 
continue to rise in Bangladesh. To the best of our knowledge there is no 
population based study yet in Bangladeshi general population to estimate the 
magnitude of retinopathy. However, the identified risk factors for retinopathy 
established by others have not been extensively studied in our population. 
The absence of reliable population based epidemiological data on retinopathy 
in Bangladesh is a serious impediment to the effective national planning of 
eye care programmes. In the above context, we planned to carry out an 
epidemiological study to create a baseline data focused on retinopathy. This 
would be the first effort to estimate the prevalence of retinopathy among 
diabetic and non diabetic population in Bangladesh and to identify the 
associated risk factors for developing retinopathy among adults. 
 
MATERIALS AND METHODS 
Study area and population 
Bangladesh has 64 districts and the study was conducted in one district of 
northern Bangladesh called Thakurgaon. Thakurgaon is in the north-west 
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corner of Bangladesh, it is about 467 km from Dhaka, the capital of 
Bangladesh. The district is a part of the Himalayan plain land and the state of 
India lies on its west and north side. This district has 5 upazilas (sub-district). 
Subjects were recruited from all upazilas by following simple random 
procedure. A total of 836 subjects participated in the study. This study was 
only a part of an ongoing large epidemiologic study of Bangladesh Diabetic 
Somity, involving a representative population of Thakurgaon district. For this 
subset of population for DM and retinopathy a sample size calculation was 
performed for diabetes prevalence (paper 1). Following a simple random 
procedure 1000 individuals aged ≥25 years were identified to participate in 
this study. Among them 836 individuals agreed to participate and were 
investigated in the present study.  
Ethical consideration 
The protocol was approved by the Norwegian Ethical Committee for Medical 
Research and the National Ethical Committee of Bangladesh. Administrative 
clearance was obtained from Bangladesh Ministry of Public Health, the 
District Medical Officer and local official institutes. All participants signed an 
informed consent form prior to commencing any study procedure. However, 
the participants who were illiterate gave verbal consent and the witness 
signed on the document on behalf of the participant. They were informed of 
their rights to withdraw from the study at any stage of the study without 
giving any notification of reasons. The written results of medical examination 
were distributed and explained to the participants through Thakurgaon 
Swasthoseba Hospital, the Health Care Center of the Bangladesh Diabetic 
Somity. The identified cases for diabetes and retinopathy were referred to this 
hospital for follow up and further treatment.   
Survey procedures 
The study was a population based cross-sectional study. This epidemiological 
survey was conducted through screening in camp settings. Three camps were 
organized in 3 different places by Thakurgaon Swasthoseba Hospital within 6 
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months. The first camp was held on June 2008, second camp on August 2008 
and the last camp on December 2008. Each camp continued for two days.  
Sixteen field assistants were recruited from the local community and trained 
for the field work which included sample selections, organizing the screening 
camps, collection of data by reviewing the questionnaire and delivering the 
results to the participants. Seven days of training were provided to the 
assistants for selection process, interview and data collection prior to the 
commencement of the study. Each trainee was evaluated before he or she was 
allowed to participate in the study. The field assistants listed all the adults 
aged ≥25 years from each area and identified the required number of subjects 
following simple random procedure. Pregnant women and physically or 
mentally disabled persons unable to follow simple questions were excluded 
from the study.  
All the individuals selected for the study were given an identification 
number. The field assistants approached the potential participants by an 
information letter and a respond document. Participants were informed of the 
purpose and the procedure of the study and they were requested to attend the 
screening camps in the morning on a pre-arranged date after an overnight fast 
of at least 8-10 hours. Each and every subject was made aware and was 
explained the necessity of the fasting state of a minimum 8-10 hr prior to the 
test. On arrival at the pre scheduled time (7.30 am to 8.30 am) on the 
appointed day, confirmation of the fasting state was verified once again from 
each participant by asking the fasting state. After receiving the consent 
general registration of the participant was initiated. With proper aseptic 
precaution, initial 8 ml of venous blood and urine sample were collected from 
each participant. Fasting blood glucose (FBG), lipid profile, serum creatinine 
and glycosylated hemoglobin (HbA1c) were determined from fasting blood 
sample and albumin creatinine ratio (ACR) was measured from urine sample. 
All subjects other than those with known diabetes (n=22) were then given a 
75-g oral glucose solution (75-g oral glucose load dissolved in 500 ml of water) 
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to drink. Another 3 ml of venous blood was collected after 2 hours to 
determine 2 hr post oral glucose tolerance test (OGTT). 
During the 2 hr waiting period the participants were interviewed for some 
general information through the preseted questionnaire and were measured 
some biophysical parameters which include anthropometric (height, weight, 
waist circumference and hip circumference) and blood pressure 
measurements. Further comprehensive ocular examinations were performed 
on each subject by trained technical assistants and ophthalmologists.  
After collecting the blood and urine sample it was centrifuged on the site 
within 3 hours to separate plasma. All samples were then refrigerated and 
stored at -200C until laboratory assays was done. Fasting blood glucose (FBG) 
and oral glucose tolerance test (OGTT) were analyzed by glucose oxidase 
method (Randox, UK) for the diagnosis of diabetes mellitus. Lipid profile 
includes total cholesterol (TC), high-density lipoprotein (HDL), low-density 
lipoprotein (LDL) and triglycerides (TG), which were measured by enzymatic 
technique. Glycosylated hemoglobin (HbA1c) was measured by high-
performance liquid chromatography (HPLC). 
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Interviewer administered questionnaire:  
The preseted questionnaire was composed of some general information; like 
the demographic and socioeconomic information, including name, sex, age, 
education, occupation and economic status. The participants were asked for 
their 1st degree family history of diabetes, associated complications of 
diabetes, if any, (nephropathy, neuropathy, hypertension, hyperlipidaemia, 
coronary artery diseases) and information related to their own medical 
history of obesity, hypertension, diabetes and associated complications of 
diabetes. They were also asked for the ocular history which includes details of 
first and last eye examination, nature of present eye complaint or any ocular 
surgery. 
Anthropometrical measurement 
Anthropometric measurements included height, weight, waist circumference 
and hip circumference. The measurements were taken with light clothes 
without shoes. Height was measured by using a portable, locally 
manufactured, stadiometer, standing upright on a flat surface without shoes 
to the nearest 0.1 cm. Body weight was measured while wearing light clothes 
by an adjusted scale and recorded to the nearest 0.1 kg. Body mass index 
(BMI) was calculated by the formula: weight in kilograms divided by height 
in meters squared. Waist circumference was measured at 1 cm above the level 
of navel at minimal respiration and hip circumference was measured at the 
level of maximum posterior extension of the buttocks by placing a flexible 
plastic tape horizontally with light clothes. Both circumferences were 
recorded to the nearest 0.1 cm. Two readings of height, weight, waist 
circumference and hip circumference were recorded and the mean of the two 
was taken as the final reading. Asian BMI criteria were used to identify 
overweight and obese in this population (23). Five categories of BMI were 
identified here for presenting the data. Individuals with BMI below 18.49 
kg/m2 classified as  underweight, healthy weight (BMI  18.5-22.9  kg/m2), 
overweight (BMI  23.0-24.99  kg/m2), obese I (BMI 25.0-29.99 kg/m2)  and 
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obese II (BMI over 30.0  kg/m2)), respectively. Abdominal obesity was 
evaluated by waist/hip ratio, with android and gynaecoid cut off points taken 
at 0.8 and 0.9 for females and males respectively (24). 
Blood pressure measurement 
Blood pressure was taken after completion of the questionnaire. To reduce the 
variation, subjects rested for at least 10 minutes before the BP was recorded. 
The pressure was measured in sitting position on the right arm using normal 
cuffs for adults fitted with a standard mercury sphygmomanometer, placing 
the stethoscope bell lightly over the brachial artery. BP was usually recorded 
to the nearest 2 mm Hg from the top of the mercury meniscus. Two readings 
were taken 5 minutes apart, and the mean of the two was taken as the final 
blood pressure reading of the individual. Hypertension was defined as a 
systolic blood pressure (SBP) of ≥ 140 mm Hg and/or diastolic blood pressure 
(DBP) of ≥ 90 mm Hg (25). 
Ophthalmologic examinations 
All the participants were gone through a complete ocular examination on that 
prearranged day by trained ophthalmologists. Visual acuity was recorded 
with an illuminated Snellen chart. The presenting and best corrected visual 
acuity was documented separately for each eye. Intraocular pressure 
measurement was performed with Schiotz indentation tonometer (Schiotz, 
John Weiss & Son Ltd, London, UK). Slit lamp was used for anterior segment 
evaluation including the depth of anterior chamber and rubeosis irids with 
diluted pupils. Fundus photography was operating with a digital camera 
(Super 66 equipped with stereo fundus lens). Dilated fundus evaluation was 
done with binocular indirect opthalmoscope (Keeler Instrument Inc, PA, 
USA). The photographs were taken in a dark room after a 5 minute 
adaptation period to allow the pupils to dilate to some extent and were 
analyzed by two ophthalmologist specialized in retinal diseases. World 
Health Organization recommended definitions of retinopathy, vision, and 
visual disability (ICD 10) was used (25). Among 836 participants 45 were 
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identified with retinopathy and were referred to the Thakurgaon Swasthoseba 
Hospital, the Health Care Center of the Bangladesh Diabetic Somity for 
further treatment and follow-up.  
Diagnosis criteria for diabetes 
After estimation of fasting blood glucose (FBG) and oral glucose tolerance test 
(OGTT), the participants were classified into non diabetes, diabetes mellitus, 
IFG (impaired fasting glucose) and IGT (impaired glucose tolerance), 
according to the recommendations of the World Health Organization Expert 
Committee (25).  Subjects were defined as having diabetes mellitus (n = 60) 
based on their fasting blood glucose levels ≥ 7.0 mmol/l or 2 hr post glucose 
levels ≥11.1 mmol/l or both. IFG was defined when FBG values were between 
6.1-7.0 mmol/l and OGTT <7.8 mmol/l. IGT was defined when FBG <7.0 
mmol/l and OGTT values were between 7.8-11.1 mmol/l. IFG and IGT 
subjects were together called pre diabetes (n = 54). Thirteen retinopathy cases 
were identified from the diabetic subjects and 7 were from pre diabetic 
subjects. The rest 25 retinopathy cases are non diabetic subjects. 
Criteria for other variables 
According to the ADA recommendation (26) the cut of value of other 
variables like, total cholesterol (<200 mg/dl), triglyceride (<150 mg/dl), LDL 
(<100 mg/dl), HDL (for male >50 mg/dl and for female >40 mg/dl), serum 
creatinine (for male <1.4 mg/dl and for female <1.2 mg/dl) and urine 
albumin creatinine ratio (<30 mg/g) was used for data analysis. 
 
Data analysis 
The data was entered in the pre-designed Microsoft office excel format which 
was imported later into the statistical software SPSS. The prevalence rates of 
retinopathy were determined by simple percentages. Statistical comparisons 
between categorical variables were made by using χ2 test and comparisons 
between continuous variables were made by using independent sample t test. 
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The odds ratio (OR) with 95% confidence interval (CI) for risk factors was 
calculated assuming the least prevalence of clinically relevant criteria as a 
reference value. Multiple logistic regression were performed to quantify the 
individual effect of predictor variables and to adjust for potential 
confounding factors. All P-values presented are two-tailed.  The statistical 
tests were considered significant at a level ≤5% (≤0.05). All the statistical 
analysis were performed using SPSS 16 software. 
RESULTS 
Table P2.1:  Distribution of participants for different variables by age and 
gender 
25-40 yrs 41-55 yrs above 55 yrs  
Variables Male 
(n=162) 
Female 
(n=164) 
P for 
differ
ence 
Male 
(n=172) 
Female 
(n=128) 
P for 
diffe
rence 
Male 
(n=134) 
Female 
(n=76) 
P for 
diffe
rence 
BMI (kg/m2) 21.4±3.2 21.6±3.5 0.650 22.3±3.6 21.8±3.7 0.141 22.9±4.2 22.5±4.6 0.585 
WHR* 0.89±0.06 0.87±0.07 0.018 0.92±0.07 0.88±0.07 0.001 0.93±0.07 0.92±0.08 0.122 
SBP (mmHg) 117.7±15.4 113.4±15.8 0.014 119.7±16.8 121.3±22.6 0.490 123.7±19.1 125.1±20.1 0.418 
DBP (mmHg) 77.5±10.8 74.6±11.6 0.029 78.2±11.4 80.3±15.5 0.253 78.7±12.9 81.2±15.0 0.196 
FBG (mmol/l) 5.03±1.7 5.05±1.8 0.913 5.1±1.5 5.3±2.1 0.277 5.2±1.4 5.7±2.3 0.142 
AG (mmol/l) 5.9±2.3 6.2±2.6 0.209 6.1±2.7 6.4±3.1 0.325 6.4±3.0 7.3±4.5 0.146 
HbA1c (%) 4.9±1.2 5.01±1.1 0.480 5.1±1.3 5.1±1.2 0.996 5.4±1.4 5.8±1.9 0.172 
SCreatinine 
(mg/dl) * 
1.12±0.23 1.03±0.21 0.001 1.24±0.33 1.16±0.26 0.050 1.40±0.40 1.31±0.43 0.062 
Trygliceride 
(mg/dl) 
156.4±65.3 135.9±54.7 0.002 156.6±62.1 155.7±56.9 0.936 162.2±65.3 163.4±71.9 0.912 
Cholesterol 
(mg/dl) 
187.3±32.4 178.0±32.9 0.013 189.5±40.6 192.9±35.2 0.642 190.8±40.3 198.3±40.5 0.068 
HDL (mg/dl)* 36.8±8.4 34.1±8.3 0.010 37.8±11.1 34.8±7.4 0.002 38.0±11.2 37.3±8.6 0.615 
LDL (mg/dl) 119.7±29.6 116.5±30 0.332 127.1±37.6 126.2±33.6 0.702 118.2±37.1 124.1±39.4 0.310 
UACR (mg/g) 13.7±6.2 13.9±5.8 0.996 13.9±6.7 14.7±6.9 0.470 18.3±7.9 18.7±8.4 0.824 
Abbreviations: BMI, Body mass index; WHR, Waist hip ratio; SBP, Systolic blood pressure; DBP, 
Diastolic blood pressure; FBG, Fasting blood glucose; AG, After 2 hr glucose load; HbA1c, 
Glycosylated hemoglobin; HDL, High density lipoprotein; LDL, Low density lipoprotein; UACR, 
Urine albumin creatinine ratio. 
* Data were coded with reference value separately for male and female and then analyzed together.  
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General characteristics of the participants are presented by gender in table 1 
with 15 years age interval. Among the 836 participants 56% (n=468) were 
male and 44% (n=368) were female participants. The mean age of the 
participants was 46 years. Male subjects were older compared to the female 
participants. There were no differences in BMI between male and female 
participants in all age strata. The mean BMI was 22.2 and 21.9 for the male 
and female participants, respectively and showed some what increased mean 
BMI with increasing age. This picture is also reflected in the assessment of 
other parameters except for LDL. In younger age group there were significant 
differences in systolic blood pressure, diastolic blood pressure, triglyceride 
and total cholesterol between male and female participants. But it was not 
depicted in other age groups.  
Table P2.2: Baseline characteristics of people with retinopathy and without 
retinopathy in diabetes and non diabetes group 
Retinopathy Diabetes Non Diabetes  
Variables Yes  
(n=45) 
No 
(n=791) 
 
P for 
differe
nce 
With 
Retinopathy 
(n=13) 
Without 
Retinopathy 
(n=47) 
 
P for 
differe
nce 
With 
Retinopathy 
(n=32) 
Without 
Retinopathy 
(n=744) 
 
P for 
differe
nce 
NGM/ IGM/ 
DM ratio 
25:7:13 697:47:47        
Age (yrs)  52.6±8.4 45.3±11.7 <0.001 56.7±6.8 46.5±9.7 <0.001 50.8±8.5 45.2±11.8 <0.001 
BMI (kg/m2) 24.1±4.3 21.9±3.7 0.002 26.9±3.8 22.9±4.5 0.004 22.9±3.9 21.8±3.6 0.140 
WHR * 0.94±0.09 0.90 ±0.07 0.002 1.03±0.11 0.96±0.09 0.249 0.92 ±0.07 0.89±0.07 0.039 
SBP (mmHg) 130.8±19.5 118.8±18.1 <0.001 136.5±15.9 127.5±19.1 0.079 128.4±20.5 118.2±17.9 0.009 
DBP (mmHg) 85.8±15.9 77.7±12.5 0.002 93.1±13.1 83.8±15.8 0.043 82.6±16.1 74.3±12.2 0.049 
FBG (mmol/l) 6.8±3.01 5.1±1.67 0.001 10.9±2.3 10.3±3.3 0.438 5.1±0.9 4.7±0.7 0.040 
AG (mmol/l) 9.1±4.1 6.1±3.0 0.001 16.7±4.9 14.5±3.7 0.151 6.1±1.8 5.6±1.4 0.131 
HbA1c (%) 6.96±2.7 5.09±1.16 <0.001 11.0±1.2 8.6±1.3 <0.001 5.3±0.81 4.9±0.87 0.011 
SCreatinine 
(mg/dl) * 
1.67±0.57 1.18±0.30 <0.001 2.31±0.49 1.48±0.50 <0.001 1.41±0.37 1.16±0.27 <0.001 
Trygliceride 
(mg/dl) 
189.7±75.5 151.9±61.3 0.003 260.5±63.4 247.1±77.3 0.533 160.9±68.5 145.9±54.8 0.230 
Cholesterol 
(mg/dl) 
216.3±46.4 187.2±35.6 <0.001 250.7±42.2 210.3±44.0 0.007 202.3±40.8 185.7±35.5 0.031 
HDL (mg/dl) * 34.7±8.9 36.9±10.1 0.119 33.7±8.6 34.5±9.6 0.798 35.1±9.1 37.0±10.0 0.246 
LDL (mg/dl) 143.6±39.1 120.7±34.2 <0.001 167.3±37.0 127.6±44.8 0.003 133.9±36.7 120.2±33.3 0.046 
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UACR (mg/g) 21.5±8.1 14.3±7.2 <0.001 23.9±8.4 16.9±7.6 0.014 20.5±7.8 12.4±6.4 0.018 
Data are presented as mean±SD; independent t- test was done as a test of significance.  
Abbreviations: BMI, Body mass index; WHR, Waist hip ratio; SBP, Systolic blood pressure; DBP, 
Diastolic blood pressure; FBG, Fasting blood glucose; AG, After 2 hr glucose load; HbA1c, 
Glycosylated hemoglobin; HDL, High density lipoprotein; LDL, Low density lipoprotein; UACR, 
Urine albumin creatinine ratio 
* Data were coded with reference value separately for male and female and then analyzed together.  
Forty five individuals were found to have retinopathy among 836 participants 
which included diabetic, prediabetic and nondiabetic population. The 
baseline characteristics were compared between subjects with and without 
retinopathy (Table 2). The subjects with retinopathy were significantly older 
with higher BMI, WHR, blood pressure, serum glucose (fasting and 2 hr after 
glucose), HbA1c, serum creatinine, triglyceride, total cholesterol, LDL, UACR 
compared to subjects without retinopathy. Although non significant subjects 
who developed retinopathy had lower HDL compared to subjects without 
retinopathy. 
Diabetic subjects (n=60), with diabetic retinopathy had significantly higher 
age, BMI, diastolic blood pressure, HbA1c, serum creatinine, total cholesterol, 
LDL and UACR compared to subjects without retinopathy (Table 2). 
However, higher WHR, systolic blood pressure, serum glucose (fasting and 2 
hr after glucose), triglyceride and low level of HDL were not found to be 
significantly associated with increasing the prevalence of retinopathy among 
the diabetic subjects. On the contrary, age, WHR, blood pressure, serum 
fasting glucose, HbA1c, serum creatinine, total cholesterol, LDL and UACR 
were significantly higher in individuals with retinopathy among the non 
diabetic individuals (n=776). Subjects with diabetic retinopathy were 
significantly older with higher BMI, WHR, diastolic blood pressure, serum 
glucose (fasting and 2 hr after glucose), HbA1c, serum creatinine, triglyceride, 
total cholesterol and LDL compared to those with retinopathy but without 
diabetes (data has not shown). 
 
 90
Table P2.3: Prevalence rate of retinopathy by age and glucose metabolism 
category 
Retinopathy cases Prevalence per 100  
Age group 
in years 
 
Male  
 
Female  
Male Female Male Female 
Total 
prevalence 
(%) 
P for 
difference 
 
25-40 yrs 162 164 4 6 2.5 3.7 3.1 0.533 
41-55 yrs 172 128 8 6 4.7 4.7 4.7 0.988 
above 55 yrs 134 76 11 10 8.2 13.1 10.7 0.151 
Total 468 368 23 22 4.9 5.9 5.4 0.499 
 
Retinopathy cases Prevalence per 100 Glucose 
Metabolism 
Category 
Male Female 
Male Female Male Female 
Total 
prevalence 
(%) 
P for 
difference 
 
DM 32 28 9 4 28.1 14.3 21.6 0.094 
Pre DM 26 28 3 4 11.5 14.3 13.0 0.764 
NGM 410 312 11 14 2.7 4.5 3.5 0.189 
Abbreviations: DM, Diabetes Mellitus; Pre DM, Pre Diabetes Mellitus; NGM, Normal Glucose 
Metabolism;  
The overall prevalence rate of retinopathy was 5.4% and the prevalence 
increased with increasing age both for males and females (Table 3). Though 
non-significant, females had higher prevalence of retinopathy compared with 
males in all age groups. The difference in prevalence of retinopathy by sex 
widened in the older age group (>55 years). Moreover, we found that the 
prevalence of retinopathy was 21.6% among the diabetic subjects (DM), 13% 
among the prediabetic subjects (Pre DM) and 3.5% among the nondiabetic 
subjects (NGM), respectively. Males had higher prevalence of retinopathy 
compared with females in diabetes group. On the contrary, females had 
higher prevalence of retinopathy compared with males in prediabetes and 
nondiabetes group. 
Table P2.4: Prevalence, odds ratio (OR) and 95% CI of Retinopathy by the 
following risk factors in the study population 
Variables Retinopathy 
cases 
n Prevalence 
per 100 
OR 1 (95% CI) OR 2 (95% CI) 
Age (yrs)      
25-40 yrs * 10 326 3.1 1.0 1.0 
41-55 yrs 14 300 4.7 3.51 (1.82-7.61) 1.97 (1.55-4.66) 
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Above 55 yrs 21 210 10.0 2.32 (1.43-4.60) 1.86 (1.24-4.17)  
Sex      
Male * 23 468 4.9 1.0 1.0 
Female 22 368 6.0 1.23 (0.67-2.24) 1.63 (0.78-3.12) 
Glucose metabolism 
category 
     
Normal Glucose 
Metabolism (NGM) * 
25 722 3.5 1.0 1.0 
Prediabetes Mellitus (Pre 
DM) 
7 54 13.0 1.98 (1.21-5.07) 1.75 (0.99-4.34) 
Diabetes Mellitus (DM) 13 60 21.6 3.61 (1.82-6.40) 2.53 (1.52-5.41) 
BMI (kg/m2)      
18.5-22.99 normal * 12 377 3.18 1.0 1.0 
Below 18.49 underweight  11 173 6.35 0.87 (0.46-2.53) 0.69 (0.40-2.37) 
23.0-24.99 overweight 8 60 13.3 0.59 (0.38-1.32) 0.49 (0.18-1.23) 
25.0-29.99 obese I 7 180 3.89 2.64 (1.68-9.37) 2.44 (1.51-7.02) 
Above 30.0 obese II 7 46 15.21 4.43 (1.87-13.37) 3.83 (1.74-12.85) 
WHR      
Normal * 10 226 4.4 1.0 1.0 
High 35 610 5.7 1.32 (0.64-2.70) 0.87 (0.29-1.71) 
SBP (mmHg)      
Below 140 * 24 663 3.6 1.0 1.0 
Above 140 high 21 173 12.1 3.68 (1.80-6.78) 1.81 (1.25-5.90) 
DBP (mmHg)      
Below 90 * 23 657 3.5 1.0 1.0 
Above 90 high 22 179 12.3 3.86 (2.14-7.11) 1.76 (1.16-5.67) 
Hypertension      
No * 24 664 3.6 1.0 1.0 
Yes 21 172 12.2 3.56 (1.87-6.06) 1.98 (1.17-5.63) 
HbA1c (%)      
Below 5.2 * 19 492 3.9 1.0 1.0 
5.3 – 5.7 8 208 3.9 3.60 (1.85-7.02) 1.74 (1.09-3.02) 
Above 5.8 18 136 13.2 4.38 (1.98-10.80) 3.10 (1.24-8.31) 
S Creatinine (mg/dl)      
Normal * 23 671 3.4 1.0 1.0 
High 22 165 13.3 4.33 (2.35-7.99) 3.22 (1.53-6.76) 
Triglyceride (mg/dl)      
Below 150 * 16 475 3.4 1.0 1.0 
Above 150 29 361 8.03 2.51 (1.34-4.69) 1.27 (0.61-2.66) 
Cholesterol (mg/dl)      
Below 200 * 19 584 3.2 1.0 1.0 
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Above 200 26 224 11.6 3.42 (1.86-6.31) 2.46 (1.44-5.29) 
LDL (mg/dl)      
Below 100 * 9 251 3.6 1.0 1.0 
Above 100 36 585 6.1 1.76 (0.84-3.72) 0.95 (0.34-2.16) 
UACR (mg/g)      
Below 30 * 34 312 10.8 1.0 1.0 
Above 30 11 45 24.4 2.65 (1.53-5.69) 1.63 (1.08-3.12) 
Abbreviations: OR, Odds ratio; CI, Confidence interval; BMI, Body mass index; WHR, Waist hip 
ratio; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; HbA1c, Glycosylated hemoglobin; 
LDL, Low density lipoprotein; UACR, Urine albumin creatinine ratio 
OR 1, Crude odds ratio after univariate logistic regression; OR 2, Adjusted odds ratio for age, sex, 
glucose metabolism category, BMI, WHR, SBP, DBP, hypertension, HbA1c, S Creatinine, Lipids and 
UACR  
* Referent  
We used logistic regression to quantify the individual effects of age, sex, 
glucose metabolism category, BMI, WHR, SBP, DBP, hypertension, HbA1c, S 
Creatinine, Lipids and UACR with diabetes (Table 4). Age, glucose 
metabolism category, BMI, SBP, DBP, hypertension, HbA1c, S Creatinine, 
triglyceride, total cholesterol and UACR were found to be significant risk 
factors for the occurrence of retinopathy in the univariate model. After 
adjusting for potential confounders in the multivariate model by using all 
variables in the model age, DM, BMI, SBP, DBP, hypertension, HbA1c, S 
Creatinine, total cholesterol and UACR remained as significant independent 
risk indicators for the occurrence of retinopathy in this population. The risk 
for retinopathy was almost 2-fold in subjects who were above 40 years with 
fasting glucose of ≥6.1 mmol/l, BMI >25.0 kg/m2, hypertensive, increased 
HbA1c level of above 5.3%, high serum creatinine for both sex, cholesterol 
>200 mg/dl and UACR >30 mg/g. 
DISCUSSION 
Only a few population based research has been performed on the prevalence 
of retinopathy in general population as well as at different levels of 
hyperglycemia, such as, diabetes mellitus, impaired glucose tolerance, 
impaired fasting glucose and normal glucose tolerance. So far there is no 
study in Indian subcontinent on such diseases group of populations. Few 
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studies have been done on Indian population which highlighted the 
prevalence of diabetic retinopathy, the microvascular complication of diabetes 
mellitus among known diabetic and newly diagnosed diabetic individuals (6, 
8, 9, 36, 37). Not only the patients with diabetes mellitus, but elderly 
individuals with prediabetes (IGT and IFG) and normal glucose metabolism 
have a substantial risk of developing retinopathy. Our survey is the first 
representative study concerning the prevalence and associated risk indicators 
of retinopathy in rural Bangladeshi adults. This research provides vital 
epidemiological data regarding retinopathy among diabetes and nondiabetes 
population in the country that will be useful for the rational planning and 
implementation of organized eye care service delivery. Our findings indicate 
a high prevalence rate of retinopathy among general population and higher 
age, glucose metabolism, BMI, hypertension, HbA1c, serum creatinine, total 
cholesterol and UACR are significant independent risk indicators for the 
occurrence of retinopathy in this population. 
Prevalence of retinopathy was found 21.6% (95% CI 11.2-32.0) among the 
diabetic subjects, 13% (95% CI 3.4-22.6) among the prediabetic subjects and 
3.5% (95% CI 2.2-4.8) among the nondiabetic subjects, respectively. The age 
standardized prevalence of retinopathy was calculated at 5.4% (95% CI 3.9-
6.9) among 836 people aged 25 years and older that were examined in the 
course of this study. We have found a higher prevalence of DM in this study 
population and the prevalence of retinopathy was increased in the subjects 
with increasing deciles of glycemic level. The prevalence rate of retinopathy 
in different glucose metabolism categories documented in this study was 
comparatively similar to other two recent European studies. A population 
based Hoorn study with cohort design found the incidence of retinopathy as 
17.5% in DM, 13.6% in IGT and 7.3% in NGM subjects (29). Another cross-
sectional study done in Finland estimated the prevalence of retinopathy as 
25% in DM, 2% in IGT and 3% in normoglycemic or NGM subjects (30). Early 
epidemiological evidences showed that the prevalence of retinopathy is 
increased in the subjects whose glycemic values were in the highest two or 
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three deciles in population with a high prevalence of diabetes (31, 32). As the 
consequences of increasing number of diabetic subjects, the number of DM 
with its associated complications like retinopathy would also rise in 
Bangladesh. Moreover, a high prevalence of retinopathy was found in this 
study in normoglycemic subjects, as in the other studies (31-33). As there is no 
previous study in Bangladesh, therefore, it is difficult to make a scientific 
comprehension of the rising trend of retinopathy.  
In this study population, retinopathy tended to be associated with several 
factors such as, increased age, glucose metabolism category, higher BMI, 
hypertension, HbA1c level, serum creatinine, total cholesterol and UACR. In 
the present study females had higher prevalence of retinopathy compared 
with males in all age groups but it did not show any significant difference in 
accordance with findings in other DM population (34, 35). Though non-
significant, the current data showed that males had higher prevalence of 
retinopathy compared with females in diabetes group. Retinopathy in 
diabetes population appeared to be prevalent more in males compared to 
females has been reported from CURES Eye study, UKPDS study, and 
Hyderabad study (6, 9, 36, 38). In contrast to other studies (29, 35), however, 
the prevalence of retinopathy in our study had a significant tendency to get 
higher with increasing age. Our study confirmed the well known positive 
association between hyperglycemic status and retinopathy. This result in 
accordance with those of previous studies (12-14, 39), have shown retinopathy 
to be associated with glucose metabolism status or with high fasting blood 
glucose levels. There is strong evidence to suggest that the development and 
progression of retinopathy is influenced by glycosylated hemoglobin (HbA1c) 
level (40-44) which was also reflected in our study. The cumulative prevalence 
increased from 3.9% for those in the lowest to 13.2% for those in the highest 
tertile of HbA1c level. Risk for developing retinopathy increased with HbA1c 
level.  
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BMI, the indicator for general obesity seemed to indicate a high risk of 
developing retinopathy in this population. In line with our study, a positive 
association between BMI and retinopathy was found in few studies (40, 45, 46, 
47) that included diabetic subjects. On the other hand, BMI did not manifest 
as a risk factor for retinopathy among diabetic subjects in CURES Eye study. 
WHR, the indicator for central obesity was also an independent risk factor for 
developing retinopathy in diabetic subjects (42, 44) as well as in nondiabetic 
subjects (29). After adjustment for potential confounders in multivariate 
model WHR did not remain as significant independent risk indicators for the 
occurrence of retinopathy in this population. The estimated risk for 
developing retinopathy in individuals with hypertension was almost 2 times 
as high as in individuals without hypertension, which remained after 
adjustment for possible confounders. This is in line with previous findings of 
incident retinopathy in studies (35, 43, 45, 48) of diabetic subjects and in the 2 
other studies (49, 50) that included nondiabetic individuals. The present study 
did not find a statistically significant association between serum triglyceride, 
HDL cholesterol and LDL cholesterol and occurrence of retinopathy. 
Association between cholesterol and prevalence of retinopathy, although not 
always statistically significant in multivariate risk models, were described in 
several studies (42, 44, 45, 51) that included diabetes subjects. Cross-sectional 
data (52, 53) have shown that hard exudates in particular are associated with 
elevated cholesterol levels. In the present study risk for retinopathy in 
subjects with high level of cholesterol was more than 2 times as high as in 
subjects with normal cholesterol level. Cross-sectional (37) and longitudinal 
studies (54, 55) report a relationship between microalbuminuria and 
retinopathy. Elevated serum creatinine and urine albumin creatinine ratio 
were found as significant risk indicators for developing retinopathy in this 
population. The present findings of the combination of these risk indicators 
for predicting retinopathy may suggest that insulin resistance or associated 
factors are implicated in the pathogenesis of retinopathy. 
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The current study had some limitations. First, the evaluation was presented 
by cross-sectional design. Second, it can be argued that the sample size 
calculation was not properly done for estimating the prevalence of 
retinopathy in this population. So far, no data has been generated either in 
Bangladesh or in the Asian subcontinent on the extent of retinopathy and its 
association with glucose metabolism including nondiabetic general people as 
well, which could we use to estimate our desired sample size. The strong 
point of this study was that the diagnosis of retinopathy was based on retinal 
photograph using fundus camera through dilated pupils, instead of 
nonmydriatic photograph. It has been argued that the use of nonmydriatic 
camera results in a moderately high frequency of ungradable photograph, 
especially in the presence of media opacities (27, 28).   
In conclusion, the present data suggest that, in addition to serum glucose 
control in diabetic patients, screening for hypertension, general obesity, 
hypercholesterolemia and proteinuria (urine albumin creatine ratio) and 
adequate treatment of these risk factors help to prevent retinopathy in 
diabetic and nondiabetic individuals.  This work gives new information on 
the prevalence and associated risk indicators of retinopathy in one region of 
Bangladesh. While there were imperfection in the design and execution of the 
study, it does highlight several problems that must be addressed and 
overcome if definitive data are to be produced from subsequent studies. 
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9  APPENDICES 
9.1 Appendix 1 
QUESTIONNAIRE 
Questionnaire 
Diabetes & Eye Camp 
 
 
Date: Place: 
ID No:  
Name:  
Age:  
Sex:  
Marital status:                
Address:  
Contact No:  
Education:  
Occupation:  
Family Member:  
Monthly Income:  
Monthly expenditure:  
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Anthropometry:  
1st reading - a) Height (cm): 
2nd reading - 
1st reading - b) Weight (Kg): 
2nd reading - 
c) BMI (kg/m2):  
1st reading - d) Waist (cm): 
2nd reading - 
1st reading - e) Hip (cm): 
2nd reading - 
f) Waist/Hip ratio:  
1st reading - Blood Pressure: 
2nd reading - 
History of Diabetes:  Yes  / No                                     Duration: 
Family History of DM:  Yes / No  Relation:   Duration: 
Complication:  
a) Problem in eye (Retinopathy)  
b) Nephropathy 
i. Swelling of leg or face 
c) Neuropathy 
i. Lingbing                   ii. Numbness                 iii. Abnormal sensation in hand or foot 
d) Cardio vascular diseases  
e) Hypertension  
Others related complication if any   
  
History of smoking:  a) Type 
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b) Stick/ Day c) Duration 
Exercise:  
a) Type b) Duration/ Day 
Investigation Performed:  
Urine Sugar  
Urine Protein 
 
S Fasting Blood Glucose   
S Oral Glucose Tolerance Test  
S Triglyceride  
S Total Cholesterol  
S Low Density Lipoprotein  
S High Density Lipoprotein  
HbA1c  
S Creatinine  
Urine Albumin Creatinine Ratio  
 
Negative Trace 250 + 500 ++ 1000 +++ 2000 ++++ 
Negative 10 ± 30 + 100 ++ 300 +++ 
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Ocular Examination 
 
ID No:  
Name:  
Visual Acuity: Right Eye Left Eye 
i.Un aided   
ii. With glass   
iii. With Pinhole   
iv. PH+ glass   
Lids   
Conjunctiva   
Cornea   
Iris   
Pupil   
Lens   
Vitreous   
 Fundus 
Diabetic Retinopathy Right Eye Left Eye 
i. Mild   
ii. Moderate   
iii. Severe   
NPDR: 
iv. Very severe   
  
 
  
    
PDR: i. Early   
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ii. High Risk   
iii. ADED   
i. Focal   
ii. Diffuse   
iii. Ishchemic   
Maculopathy 
iv. CSMO   
Hypertensive Retinopathy   
i. CRVO   
ii. BRVO   
iii. Vascullar   
Mics: 
iv. Others   
 
Fundus Drawings: 
 
 
 
 
Notes: 
 
Optic Disc Change Right Eye Left Eye 
Colour   
CD Ratio   
Margin   
Others   
Ocular investigation and findings: 
Investigation Right Eye Left Eye 
i. CFP   
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ii.FFA   
iii. Perimetry   
iv. B scan   
v. Boimetry   
vi. Others   
Provisional Diagnosis: 
Other Investigation:  
Treatment: 
a. Medication 
b. Plan for procedure Right Eye Left Eye 
i. LASER   
ii. Operation   
iii. Others   
c. Follow up: 
Report and Remarks: 
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9.2 Appendix 2  
INFORMED CONSENT FORM 
Information and agreement paper between the subject and the researcher 
 
Letter of Information 
 
Dear Sir/Madam, 
I am a student of International Community Health at the University of Oslo, 
Norway. This letter of information is to invite you to participate in a health 
research. This project is carried out with the permission from the Norwegian 
Research ethical Committee and the National Ethical Committee of 
Bangladesh. You are selected randomly as a possible participant in this study 
because our study subjects are adults both male and females. The objective of 
the project is to estimate the prevalence and to investigate the determinants of 
diabetes and retinopathy in rural population of Bangladesh. The result of the 
study will serve as the base line data for further research regarding the 
development and management of diabetes and eye care in an attempt to 
prevent visual loss in Bangladeshi population. To do this, we have to collect 
some information from you and also need to conduct some physical and 
clinical examinations which will help to fulfill the objectives of the project 
with your kind permission. Therefore, if you agree to participate you have to 
come to the screening camp between 8.00 am to 9.00 am on the appointed day 
after fasting for at least 8-10 hours and will answer to some questions and 
have to provide blood sample twice to do some examinations. The blood will 
be drawn by a well-trained technician maintaining all aseptic measures and 
by using a small syringe.  We will use a new syringe for each participant and 
once his/her blood is drawn, it will be disposed safely.  It may make the 
participants’ feel only a little discomfort during the whole process. In the 
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phase of blood examination possible side effects may include local swelling 
after drawing blood, slight congestion, dizziness etc. However, we have been 
well prepared to protect the study subjects and to minimize potential harm to 
the lowest degree. All the participants will go through some modernized 
ocular examination during this visit to check whether they have developed 
retinopathy or not. Test results will be informed you in time. All the subjects 
with diabetes, retinopathy and diabetic retinopathy will refer you to the 
Health Care Center of the Diabetic Association of Bangladesh for further 
treatment and follow up. Choosing to participate will be advantageous to you 
for some reasons: You will know whether or not you have diabetes. 
• You will know whether or not you are about to have diabetes. 
• Knowing your diabetic status will help you to take appropriate 
decisions regarding diabetic complications. 
• You will know whether or not you have retinopathy. 
You are free to choose either to participate or not to participate in this project. 
You can trust that any information you will give us, including the results of 
your examinations, will all be treated very confidentially and will only be 
used for research purpose. For that reason, it is important that the information 
you give be as correct and truthful as possible. You also have the right to 
withdraw from the project at any time during the study without the prior 
reasons. This will have no negative consequences on you. 
May be you cannot receive too much direct benefit from taking part in this 
research, but it will have a favorable impact on public health in future. Your 
participation will contribute greatly to our research. We thank you in advance 
for agreeing to help us out. If you have any question on concern about the 
study please contact local diabetic center.   
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Respond Document 
 
I ………………………………….. hereby give my well informed and coercion 
free consent to participate in the study. I fully understand that my 
participation in the study will bring fruitful medical information which will 
be used for many other researches in future. 
I am convinced that during participation in the study, I shall not be exposed 
to any physical, psychological, social or legal risks. My privacy and 
confidentiality will be safeguarded and any anonymity will be protected. I 
also consent to use my blood and urine for the study. 
 
  
Date: ………………………. Date: ………………………. 
Signature of the participant Signature of the 
interviewer 
 
………………………………
 ………………………………
. 
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9.3 Appendix 3 
PICTURES FROM THE FIELD WORK 
 
 
 
 
Picture 1: Participants were waiting to start the survey procedure 
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Picture 2: participants were interviewed the questionnaire 
 
 
Picture 3: Field worker was calculating the anthropometric measurement  
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Picture 4: Visual acuity test 
 
 
Picture 5: Ocular examination by slit lamp 
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Picture 6: Ocular examination by ophthalmoscope 
 
 
Picture 9: Ophthalmologists were prescribing the participants   
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Picture 10: Team of the laboratory technicians 
 
Picture 11: Team of the volunteers 
